Compositions for ophthalmic products
Specific photoactive monomers and cross-linked copolymers address shimmering and calcification issues in ophthalmic lenses by maintaining transparency and refractive index change under UV light, ensuring clear vision without shimmering or calcification.
Patent Information
- Application Number
- JP2023073312
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2017-12-22
- Filing Date
- 2023-04-27
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2038-12-18
AI Technical Summary
Existing ophthalmic lenses suffer from issues such as shimmering (due to phase separation) and calcification, which can impair vision, particularly when the water content of the polymer changes with temperature, and there is a need for materials that are soft and moldable at ambient temperatures without these issues.
Development of specific photoactive monomers and cross-linked copolymers that maintain transparency and refractive index change under UV light exposure, with controlled water content to prevent shimmering and calcification, allowing for implantation at ambient temperatures between 16°C and 18°C.
The solution provides ophthalmic lenses that are transparent, non-sparkling, and resistant to calcification, with a denaturation time suitable for implantation, ensuring minimal visual impairment.
Smart Images

Figure 0007581412000001 
Figure 0007581412000002 
Figure 0007581412000003
Abstract
Description
[Technical field]
[0001] description Technical Field The present invention relates to compositions for ophthalmic products, corresponding copolymers and their preparations, and their use for the production of ophthalmic lenses or ophthalmic implants, and do. [Background technology]
[0002] Prior Art
[0003] Cataracts cause slow, painless loss of vision, especially if the opacification begins in the central region of the lens. The condition manifests as opacification of the eye lens leading to loss of vision. Affected individuals report feeling "as though they are seeing through a fog." The opacified lens is then surgically injected with a synthetic lens, known as an intraocular lens. These can in most cases be replaced by intraocular lenses (IOLs).
[0004] Many intraocular lenses are known. For example, intraocular lenses include a central optic lens and It is made of peripherally attached haptics that secure the optical lens to the eye. The haptics can have various shapes, e.g., C-loop haptics or plate haptics. Based on the material, the lenses can be rigid, non-foldable IOLs, and soft They can be divided into soft, foldable, and flexible IOLs. Hard lenses are made of polymethacrylate. The foldable lenses are made of acrylate, siloxane, or halides. The advantage of foldable lenses is that they require essentially smaller incisions for implantation. A new type of intraocular lens is the light adjustable lens (LAL). In the case of LAL, the lens's performance is determined by illumination with light of a suitable wavelength, e.g., ultraviolet light. This can be adjusted after surgery. Phakic intraocular lenses (PIOLs) are artificial lenses that are implanted into the eye in addition to the natural lens. Phakic intraocular lenses are implanted as part of the correction of incomplete vision. The PIOL is made up of a central optic lens and adjacent haptics on the periphery. Based on the localization of the PIOL in the eye, it is possible to distinguish The anterior chamber lens is placed between the cornea and the iris, and the posterior chamber lens is placed between the cornea and the iris. The anterior chamber lens is implanted between the iris and the eye lens. The anterior chamber lens is made of rigid polymethylmethacrylate. It is made of either acrylate or soft materials such as silicone or acrylic compounds. Posterior chamber lenses are generally made from soft materials.
[0005] For example, phototunable lenses contain groups that are photochemically active in the UV range. When LAL is irradiated with ultraviolet light, the polymer The first light-adjustable lenses were developed by the American ophthalmologist Dan Developed in 1999 by Dr. El Schwarz and Robert Grubbs (Daniel M. Schwartz et al, Light-adjustable lens: development of in vit in Transactions of the American Ophthalmological Society Vol 102, December 2004, 67-74).
[0006] The development of suitable materials for IOLs has progressed rapidly. 1 is a hard copolymer of ethylene glycol phenyl ether acrylate (EGP EA) and polyethylene glycol phenyl ether acrylate [(polyEG)P EA], a second monomer selected from the group of unsubstituted or substituted styrenes, and ethylenically unsaturated groups that form hydrogels as homopolymers. A hard intraocular lens is formed from the third monomer, which breaks down upon hydration. The intraocular lens is converted into a bendable intraocular lens, the lens having a refractive index of about 1.50. The report describes the production of An artificial intraocular lens formed from a polymeric material containing photochemically activatable groups is So that light-induced modification of the optical properties of the IOL can be carried out, e.g. It is known from EP1926454.
[0007] M. Schraub et al, European Polymer Journal 51 (2014) 21-27, for example, The photochemistry of polymethacrylates containing phenyl-coumarins is described.
[0008] WO2017 / 032442, WO2017 / 032444, and WO2017 / 0 No. 32443 is a patent application for the production of medical devices, preferably ophthalmic products, particularly preferably ophthalmic products. The materials for the production of the intraocular lenses are described. These materials are suitable polymers or In the preparation of the copolymer, as a photoactive monomer, it can be preferably used .
[0009] Both hydrophobic, soft acrylate and siloxane polymers have been used for intraocular These are known for use in the production of glasses and exhibit a sparkling effect. is more evident in the first mentioned polymer. A. Miyata and S. Yaguc According to hi, J Cataract Refract Surg 2004; 30:1768-1772, glitter is a phenomenon that occurs in the human eye. Phase-separation phenomena occur when the polymer is placed in an aqueous environment and the temperature is changed immediately, such as when It is an elephant.
[0010] The water content of a polymer increases with temperature. As the temperature decreases, the polymer's ability to absorb water The refractive index of the polymer phase decreases, causing phase separation. This causes the formation of vacuoles in the aqueous phase that are perceived as sparkling. The temperature dependence of the water content of the polymer is importantly determined by the temperature dependence of the water content of the polymer. The greater the number, the more severe the patient's glint-induced visual impairment may be.
[0011] The water content of a polymer can be increased by the addition of hydrophilic components during polymerization. The hydrophilic component is a non-crosslinked homopolymer that is water-soluble or swellable in water. Crosslinked copolymers containing hydrophilic components are useful for preparing hydrogels, for example. Such hydrogels can be ophthalmic materials, i.e., hydrophilic acrylates. Forming a further class of polymers. See, e.g., US 8,247,511 and Bozukova As known from D et al, Mat. Sci. Eng. 2010, 69:63-83, these are It is hard in water and becomes soft after swelling in water. The water content of such polymers is greater than 10 percent by weight. If the water content of the polymer is greater than 10 weight percent, the term hydrophilic polymer is used. , can be used.
[0012] In contrast to hydrophobic acrylate polymers, hydrogels do not exhibit sparkle, but However, as described in Trivedi et al, Eye 2002, 16: 217-241, calcification may occur in Calcification occurs mainly in the form of calcium deposits on the lens surface that obscure vision. Refers to a compound. As a result, there are two phenomena: sparkle and calcification, which are undesirable. This occurs in the case of extremely low or extremely high hydrophilicity of the polymeric material, respectively.
[0013] The object of the present invention is to provide a composition which is soft and moldable at an ambient temperature between 16°C and 18°C, Sparse enough that it exhibits little or no sparkle and at the same time calcification cannot occur A suitable polymeric material containing specific photoactive polymerizable monomers that is water-based, and The polymeric material additionally has a corresponding composition suitable for the preparation of a permeable material. For example, in the case of using an ultraviolet light source of a corresponding wavelength λ, or in the case of emitting light of a wavelength 2λ or even nλ (where n is a natural number). In using the laser, the refractive index should be changed in the exposure to select the light of wavelength λ. Furthermore, the polymeric material and the target substance comprising the polymeric material are tested in an aqueous environment at 35° C. The corresponding ophthalmic lenses have a lapse time of less than 60 seconds, preferably from 10 to 40 seconds, and particularly preferably The denaturation time for known materials is, for example, 15 to 25 seconds. For example, see Ophthalmologist, 2017, Issue #1217. Specific photoactive monomers are described, for example, in WO2017 / 032442. These are well known. This object is correspondingly achieved by the independent and dependent claims of the present application. Summary of the Invention
[0014] The appropriate selection of monomers in a composition comprising a specific photoactive monomer determines the corresponding wavelength. This leads to the preparation of transparent crosslinked copolymers that change their refractive index upon exposure to long light. , substantially without glitter and without further hydration, in accordance with the standard application according to the prior art. The temperature is 16 degrees, so that the device can be implanted in the eye, for example in the form of an intraocular lens. It was found to be soft at ambient temperatures between 18° C. In addition, the polymeric material was transparent. For example, in the case of using an ultraviolet light source of a corresponding wavelength λ, or in the case of emitting light of wavelengths up to 2λ or nλ, the corresponding wavelength is obtained by using a laser with a sufficiently high pulse frequency. The intraocular lenses are made from transparent cross-linked copolymers that change their refractive index upon exposure to λ light. The enzyme has an advantageous denaturation time.
[0015] The material preferably does not have any sparkle. "Clear" means that the copolymer is always transparent, and is used herein and in Clinical Opthalmology. According to the sparkle test as described in thalmology, 2013, 7, 1529-1534 Vacuole count is 100 / mm 3 Fewer than 25 vacuoles / mm 3 Less, and Preferably 20 vacuoles / mm3 Fewer and very particularly preferably 10 vacuoles / mm 3 Fewer than 5 vacuoles / mm 3 Less; these values are Akira Miyata. Scale 0 introduced by Miyata et al, Jpn J Ophthalmol 2001, 45, 564 - 569 Correspondingly, scale 0 to 50 vacuoles / mm 3 Less than 50 vacuoles / mm for scale 1 limit 3 and the limit of scale 2 is 100 vacuoles / mm 3 and the limit of scale 3 is 200 vacuoles / mm 3 It is written as follows.
[0016] Therefore, the present invention relates first to a composition comprising a specific photoactive monomer of formula (1) as described below, at least one hydrophilic monomer whose non-crosslinked homopolymer is water-soluble or swellable in water, an ultraviolet light absorber, and a crosslinker, wherein of all compounds of formula (1) in total, relative to the sum of all hydrophilic monomers Rumo The ratio of the fluorine-containing gas to the fluorine-containing gas is 1:0.51 to 1:1.24.
[0017] The present invention further provides for the corresponding crosslinking of copolymers of this type. The process for the preparation and the product, preferably blanks for ophthalmic lenses, ophthalmic and their use for the production of blanks for ophthalmic implants, ophthalmic lenses or ophthalmic implants. do. The invention furthermore relates to the corresponding products and to processes for the production of the products. do. Description of the invention Thus, the present invention relates first to a composition comprising: At least one compound of formula (1)
[0018] [ka] where the following applies to the symbols and indices used: X, in each occurrence, is the same or different and is O, S or NR 0 and ; Y, in each occurrence, is the same or different, O or S; X1 is O or S; a is 0 or 1; Sp is alkanediyl, alkenediyl, or alkynediyl, which is one or more and optionally substituted by a group R of the formula: R 0 is a linear or branched alkyl group having 1 to 10 carbon atoms;
[0019] R 1 , R 2 , R 3 and R 4 are mutually exclusive in each case and in each occurrence. Independently, H, F, Cl, Br, I, linear or branched alkyl groups having 1 to 20 carbon atoms Alkyl groups, partially or fully halogenated straight chain having 1-20 carbon atoms or a branched alkyl group, an aryl or heteroaryl group having 5 to 40 ring atoms. can be;
[0020] R 5 , R 6 , R 7 , R 8 and R 9 In each case, in each occurrence, and independently of each other H, F, Cl, Br, I, linear or A branched alkyl group, a linear or branched alkoxy group having 1 to 20 carbon atoms, 1 to 2 Partially or fully halogenated straight or branched chain alkoxy groups having 0 carbon atoms. alkyl groups, partially or fully halogenated straight-chain or or branched alkoxy group, or an aryl or heteroaryl group having 5 to 40 ring atoms; where R is a 5 ~R 9 At least one group from the group consisting of 1 to 20 carbon atoms represents a linear or branched alkyl group having atoms, which may be partially or completely halogenated. May be genized;
[0021] R 10 , R 11 , R 12 are, in each case and in each occurrence, Independently, H, F, a straight or branched alkyl group having 1 to 20 carbon atoms (which may be a part of halogenated, partially or fully halogenated, or having 6 to 14 carbon atoms is an aryl group;
[0022] R, in each occurrence, is the same or different and is selected from the group consisting of linear or branched alkyl groups having 1 to 10 carbon atoms, partially or fully halogenated linear or branched alkyl groups having 1 to 10 carbon atoms, linear or branched alkoxy groups having 1 to 10 carbon atoms, or partially or fully halogenated linear or branched alkoxy groups having 1 to 10 carbon atoms; at least one hydrophilic monomer, such that the non-crosslinked homopolymer is water soluble or swellable in water; at least one UV absorber and at least one crosslinker, of all compounds of formula (1) in total, relative to the sum of all hydrophilic monomers Rumo The ratio of the fluorine-containing gas to the fluorine-containing gas is 1:0.51 to 1:1.24. The term composition is used synonymously with respect to the term formulation or preparation.
[0023] The composition includes, comprises, or consists essentially of the above features or any of the features. For example, see WO2017 / 032442, pages 21-22 and 44- As described with respect to the compound of formula (1) on page 78, it may be used in a composition. All compounds or components capable of being synthesized are known and commercially available or may be used without departing from the spirit and scope of the present invention. or can be synthesized by known processes. is incorporated herein by reference. The compounds of formula (1) and preferred embodiments thereof may be prepared in any of the following stereoisomers: or a racemic mixture.
[0024] Generally, surfaces are divided into hydrophilic and hydrophobic surfaces based on their contact angle with water. The following applies: 0°< contact angle < 90° hydrophilic; contact angle > 90° hydrophobic. The contact angle at is a result of the surface structure and material. (References: R.; Schoenherr, H.; Tobias , A.; Jenkins, A. See Appendix C. In Surface Design: Applications in Bioscience and Nanotechnology; Wiley-VCH:Weinheim, Germany, 2009; page 471) Hydrophilic and phobic Aqueous fractionation is predominantly related to the volumetric properties of polymers and their individual components. and the discrimination based on the contact angle is not appropriate.
[0025] Regarding the classification of intraocular lenses into hydrophilic and hydrophobic lenses, Bozukova et al. The moisture content is indicated as a separate standard. If the moisture content is more than 10-20% by weight, If the water content is less than 10-20% by weight, it is a hydrophobic intraocular lens; In most cases, it is a hydrophilic intraocular lens (reference: Bozukova D, Pagnoulle C, Jerome R, Jerome C, (2010) Polymers in modern ophthalmic implants -Historical background and recent advances, Material Science and Engineering R 69:63-83). Water absorption of materials are parent compounds for the polymers prepared in the context of the present invention with respect to their application areas. A more appropriate criterion for hydrophilicity and hydrophobicity. For the fractionation of monomers, the fractionation described by Bozukova et al. are useful in the context of the present invention and their intended application: the monomers are completely water soluble In the case of a homopolymer having a water absorption rate of more than 10% by weight, this is It exhibits hydrophilic properties and is classified as a hydrophilic monomer for the purposes of this invention. The properties are caused by the functional groups of the monomers that are able to bind water molecules. can be seen in the expanded state in the presence of antifreeze water. Water, regardless of temperature, is bound to the polymer's functional groups, and this water This is based on the fact that ice crystals cannot form. Polymers of this type may contain freezable water that forms ice crystals, but this , due to the separation into hydrophilic and hydrophobic monomers, it is not available. Examples of functional groups that can be The monomer may be an xyl group, a sulfone group, a sulfate group, an ether bridge, or an amide group. The presence of this type of functional group in the monomer is thus indicative of a hydrophilic monomer.
[0026] Therefore, it is preferred that the monomer has one or more of the above criteria for water solubility of the resulting homopolymer. The resulting water absorption is greater than 10% by weight of the homopolymer, and / or If the presence of non-freezing water in the homopolymer as a polymer is satisfied, this is considered to be the case for the purposes of the present invention. If a monomer does not meet any of the above criteria, it is For purposes of this invention they are referred to as "non-hydrophilic monomers."
[0027] For the purposes of the present invention, a linear or branched alkyl group having 1 to 20 carbon atoms is Groups: methyl, ethyl, n-propyl, i-propyl, cyclopropyl, n-butyl, i- Butyl, s-butyl, t-butyl, cyclobutyl, 2-methylbutyl, n-pentyl, s -Pentyl, t-pentyl, 2-pentyl, neopentyl, cyclopentyl, n-hexyl s-hexyl, t-hexyl, 2-hexyl, 3-hexyl, neohexyl, 2-methyl pentyl, n-heptyl, 2-heptyl, 3-heptyl, 4-heptyl, n-octyl 2-ethylhexyl, n-nonyl, n-decyl, 2-(2,6-dimethyl)octyl , 3-(3,7-dimethyl)octyl, 1,1-dimethyl-n-hex-1-yl-, 1 ,1-Dimethyl-n-hept-1-yl-, 1,1-Dimethyl-n-oct-1-yl- , n-undecyl, n-dodecyl, 1,1-dimethyl-n-dec-1-yl-, n-trimethyl Decyl, n-tetradecyl, 1,1-dimethyl-n-dodec-1-yl-, n-heptadeca Cyl, n-hexadecyl, 1,1-dimethyl-n-tetradec-1-yl-, n-octyl Decyl, n-nonadecyl, 1,1-dimethyl-n-hexadec-1-yl-, 1,1-di Methyl-n-octadec-1-yl-, 1,1-diethyl-n-hex-1-yl-, 1 ,1-Diethyl-n-hept-1-yl-, 1,1-Diethyl-n-oct-1-yl- , 1,1-diethyl-n-dec-1-yl-, 1,1-diethyl-n-dodec-1-yl -, 1,1-diethyl-n-tetradec-1-yl-, 1,1-diethyl-n-hexadeca 1,1-diethyl-n-octadecyl-, 1,1-diethyl-n-octadecyl-, and n-eicosyl This is taken to mean "ru."
[0028] As mentioned above, a partially halogenated alkyl group is one in which at least one hydrogen atom is Linear or branched alkyl having 1 to 20 carbon atoms substituted with halogen atoms The corresponding group, but not all hydrogen atoms have been replaced with halogen atoms. The preferred halogen atom is a fluorine atom or a chlorine atom, and particularly preferred is Partially fluorinated alkyl groups (eg, 2,2,2-trifluoroethyl).
[0029] As mentioned above, a fully halogenated alkyl group is a linear alkyl group having 1 to 20 carbon atoms. It corresponds to a chain or branched alkyl group, and all hydrogen atoms are replaced with the corresponding halogen atoms. Preferred halogen atoms are fluorine and chlorine atoms, particularly preferably are fully fluorinated alkyl groups. Examples are trifluoromethyl, pentafluoromethyl, fluoroethyl, or nonafluoroethyl. For the purposes of the present invention, as defined above, alkanediyl is an alkyl group having 1 to 20 carbon atoms. The alkyl group corresponds to a divalent group derived from a straight-chain or branched alkyl group.
[0030] For the purposes of the present invention, alkenediyl is, as defined above, a straight-chain or linear alkyl group having 1 to 20 carbon atoms. A linear or branched alkene group having 1 to 20 carbon atoms, corresponding to the alkyl group of It corresponds to the divalent radical derived from the nyl group, but contains at least one double bond.
[0031] For the purposes of the present invention, alkynediyl is defined as having 1 to 20 carbon atoms, as defined above. A linear or branched alkyl group having 1 to 20 carbon atoms, corresponding to the linear or branched alkyl group corresponding to a divalent radical derived from an alkynyl group of the formula (I) but containing at least one triple bond. do. Alkanediyl, alkenediyl, or alkynediyl are each independently selected from the group R. can be substituted accordingly.
[0032] For the purposes of this invention, partially halogenated or The fully halogenated straight or branched alkoxy group has 1 to 20 carbon atoms. Partially or fully halogenated straight or branched chain alkyl groups where the alkyl group is attached to the corresponding oxygen atom to form O-alkyl. It can be abbreviated as ru.
[0033] For the purposes of the present invention, linear or branched thioalkyl groups having 1 to 20 carbon atoms are , corresponding to a linear or branched alkyl group having 1 to 20 carbon atoms, An alkyl group is attached to the corresponding sulfur atom and may be abbreviated as S-alkyl.
[0034] Cycloalkyl groups containing 3 to 8 carbon atoms are, for example, cyclopropyl ... Butyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl. which may in each case be substituted by a group R.
[0035] An aryl group in the sense of the present invention is a group having 6 to 40 aromatic ring atoms, preferably carbon atoms, A heteroaryl group in the sense of the present invention contains 5 to 40 aromatic ring atoms. wherein the ring atoms include carbon atoms and at least one heteroatom, except that The total number of atoms and heteroatoms is at least 5. The heteroatoms are preferably N, O, and / or S. The aryl or heteroaryl group is selected from a simple aromatic ring. , i.e. phenyl from benzene, or for example pyridine, pyrimidine, or thio a simple aromatic heterocycle derived from phene or a fused aryl or heteroaryl group; For example, naphthalene, anthracene, phenanthrene, quinoline, or isoquinoline It is taken to mean.
[0036] Aryl or heteroaryl groups having 5 to 40 ring atoms are each In the latter case, the aromatic or heteroaromatic group may be substituted at any desired position. The linkage may be via a substituent, for example, the following groups are taken to mean: benzene, na Phthalene, anthracene, benzanthracene, phenanthrene, benzophenanthrene , pyrene, chrysene, perylene, fluoranthene, benzofluoranthene, naphthacene, Pentacene, benzopyrene, biphenyl, biphenylene, terphenyl, terphenylene , fluorene, spirobifluorene, dihydrophenanthrene, dihydropyrene, tetrahydropyrene Hydropyrene, cis- or trans-indenofluorene, cis- or trans-mo Nobenzoindenofluorene, cis- or trans-dibenzoindenofluorene, tribenzoindenofluorene Luxene, isotruxene, spirotruxene, spiro-isotruxene, furan, benzo Zofran, isobenzofuran, dibenzofuran, thiophene, benzothiophene, isobe Benzothiophene, dibenzothiophene, pyrrole, indole, isoindole, carba azole, indolocarbazole, indenocarbazole, pyridine, quinoline, isoquinoline Phosphorus, acridine, phenanthridine, benzo-5,6-quinoline, benzo-6,7-quinoline Quinoline, benzo-7,8 quinoline, phenothiazine, phenoxazine, pyrazole, indole imidazole, benzimidazole, naphthaimidazole, phenanthimidazole Imidazole, pyridoimidazole, pyrazineimidazole, quinoxalineimidazole, oxalimidazoline Sazoxazole, benzoxazole, naphthoxazole, anthroxazole, phenanthro Oxazole, isoxazole, 1,2-thiazole, 1,3-thiazole, benzothiazole Azoles, pyridazines, benzopyridazines, pyrimidines, benzopyrimidines, quinoxazones 1,5-diazaanthracene, 2,7-diazapyrene, 2,3-diazapyrene, 1, 6-diazapyrene, 1,8-diazapyrene, 4,5-diazapyrene, 4,5,9,10- Tetraazapyrylene, pyrazine, phenazine, phenoxazine, phenothiazine, fluoro Rubin, naphthyridine, azacarbazole, benzocarboline, phenanthroline, 1, 2,3-triazole, 1,2,4-triazole, benzotriazole, 1,2,3- Oxadiazole, 1,2,4-oxadiazole, 1,2,5-oxadiazole, 1 ,3,4-Oxadiazole, 1,2,3-Thiadiazole, 1,2,4-Thiadiazole 1,2,5-thiadiazole, 1,3,4-thiadiazole, 1,3,5-triazinyl 1,2,4-triazine, 1,2,3-triazine, tetrazole, 1,2,4,5 -Tetrazine, 1,2,3,4-tetrazine, 1,2,3,5-tetrazine, purine, purine Teridine, indolizine and benzothiadiazole. An arylalkyl group is an alkyl group substituted with at least one aryl group. It is based on
[0037] An arylalkyl group is an alkyl group substituted with at least one aryl group. wherein the aryl group is substituted with at least one alkyl group. The meanings or preferred meanings given above apply to the aryl and alkyl groups. .
[0038] For purposes of the present invention, R, in each occurrence, may be the same or different and A linear or branched alkyl group having 1 to 10 carbon atoms, Partially or fully halogenated linear or branched alkyl groups, 1 to A linear or branched alkoxy group having 10 carbon atoms or a cyclic alkyl group having 1 to 10 carbon atoms. Partially halogenated or fully halogenated straight-chain or branched alkoxy groups R is preferably selected from the group consisting of methyl, ethyl, , trifluoromethyl, or methoxy. For the purposes of this invention, R 0has 1 to 10 carbon atoms, preferably 1 to 4 carbon atoms and the like. The alkyl group may be a straight or branched chain alkyl group having the following formula:
[0039] In an embodiment of the invention Y has the meaning O and X has the meaning O, S or NR 0 Have , where R 0 The compounds of formula (1) according to the invention are For caries compositions it is preferably selected.
[0040] Y has the meaning O and X has the meaning O or S, preferably Y has the meaning O and compounds of formula (1) in which X has the meaning O are suitable for the compositions according to the invention, More preferably still, the preferred compounds of formula (1) of this type are , which can be represented by equation (2):
[0041] [ka] Where X 1 ,a,Sp,R 1 ~R 12 is given above or preferably below has the stated meaning.
[0042] As described above, in the compound of formula (1) or (2), X 1 is preferably O and a corresponds to 0 or 1. When the spacer Sp has an even number of carbon atoms, In this case, a is preferably 1. In the case where the spacer Sp has an odd number of carbon atoms, a is , preferably 0.
[0043] In the compounds of formula (1) or (2), Sp is preferably an alkanediyl having 6 to 20 carbon atoms, which is R is preferably 8, 9, 10, 11, 12, 13, 14, 15, or 16 carbons It may be substituted by an alkanediyl having one or more R atoms, very Particularly preferred are alkanes having 9, 10, 11, 12, 13 or 14 carbon atoms. The alkanediyl may be substituted by diyl. The alkanediyl is preferably unsubstituted as described above. Alkanediyl is very particularly preferably 10, 11, 12 or 13. Carbon atom or -(CH2) 11 - and - (CH2) 12 -Alkanediyl having be. In the compounds of formula (1) or (2), the substitutions are as described above or preferably as described above. base R 1 , R 2 , R 3 and R 4 is preferably H, which is the compound of formula (3) This can be expressed as:
[0044] [ka] where X1, a, Sp, and R 5 ~R 12 has the meaning given above or preferably have the meaning given above or below.
[0045] In an embodiment of the present invention, a compound represented by formula (1), (2) or or (3) (wherein R 11 and R 12 denotes H, and R 10 Finger on (having the meanings indicated) are preferably selected for the compositions according to the invention.
[0046] Substituent R 10 is preferably H or 1, 2, 3, 4, 5, or 6 carbon atoms or a linear or branched alkyl group having the formula is a polysubstituted phenyl group. The substituent R of the compound of formula (1), (2), or (3) 10 is particularly preferably H, methyl, ethyl or phenyl, very particularly preferably Most often it is H or methyl.
[0047] The substituent R of the compound of formula (1), (2), or (3) 10 But as mentioned above, H These monomers are then referred to as acrylates. or the substituent R of the compound (3) 10 When, as shown above, is methyl, these moieties The monomers are then referred to as methacrylates. The acrylates are especially preferred.
[0048] As described above or preferably as described above, in the compounds of formula (1), (2) and (3), In the above, the substituent R 11 , R 12 , R 5 , R 6 , and R 8 is preferably H, can be represented by a compound of formula (4):
[0049] [ka] where X1, a, Sp, R 7 , R 8 , and R 12 means the meaning given above or preferred "Conditional Terms" has the meaning given above or below.
[0050] In the compound of formula (1), (2), (3), or (4), R 9 is 1 to 6 carbons atoms, preferably non-fluorinated, partially fluorinated, or fully is a linear or branched alkyl or alkoxy group, which is fully fluorinated, X1, a, R 7 , and R 10 or other substituent R 1 ~R 12 One of them is In the above cases, the term has the meaning or preferred meaning given above.
[0051] In the compound of formula (1), (2), (3), or (4), R 9 is one to four carbons atoms, preferably non-fluorinated, partially fluorinated, or fully is a linear or branched alkyl or alkoxy group, which is fully fluorinated, X1, a, R 7 , and R 10 or other substituent R 1 ~R 12 One of them is In the above cases, the term "a" has the meaning or preferred meaning given above.
[0052] In the compound of formula (1), (2), (3), or (4), R 7 is 2 to 8 carbons atoms, preferably non-fluorinated, partially fluorinated, or fully is a linear or branched alkyl group, which is fluorinated to a certain extent, 9 , and R 10 or other substituent R 1 ~R 12 One of the following, if they appear, is given above: has a selected or preferred meaning.
[0053] In the compound of formula (1), (2), (3), or (4), R 7 is 3 to 8 carbons atoms, preferably non-fluorinated, partially fluorinated, or fully is a linear or branched alkyl group, which is fluorinated to a certain extent, 9 , and R 10 or other substituent R 1 ~R 12 One of the following, if they appear, is given above: has a selected or preferred meaning. Preferred examples of compounds of formulae (1) to (4) selected according to the invention for the composition are: Corresponding to compounds (M-1) to (M-63):
[0054] [ka] TIFF0007581412000006.tif241146 TIFF0007581412000007.tif241161 TIFF0007581412000008.tif241145 TIFF0007581412000009.tif241150 TIFF0007581412000010.tif241152 TIFF0007581412000011.tif241148 TIFF0007581412000012.tif241144 TIFF0007581412000013.tif166162
[0055] As described above or preferably as described above, one or more of the formulas (1), (2), (3), (4) In addition to the compounds (M-1) to (M-63), the composition according to the present invention further comprises: at least one hydrophilic monomer in the molar ratio as described above or preferably as described below - is also provided. As described above, hydrophilic monomers are those whose corresponding homopolymers are soluble in water. The material is characterized by being hydrophilic or expandable in water. It has a polar group capable of coordinating with water, for example and preferably OH or They are distinguished by the presence of NH2.
[0056] Suitable examples of hydrophilic monomers include 3-hydroxypropyl methacrylate, Dipropyl acrylate, 2-hydroxyethyl methacrylate, 2-hydroxyethyl Acrylate, 4-hydroxybutyl methacrylate, 4-hydroxybutyl acryl acrylate, glyceryl methacrylate, glyceryl acrylate, acrylamide, N-vinyl pyrrolidone, 6-hydroxyhexyl methacrylate, 6-hydroxyhexyl acrylate 18-Hydroxyoctadecyl methacrylate, 18-Hydroxyoctadecyl Acrylate, 11-hydroxyundecyl methacrylate, 11-hydroxyundecyl 12-hydroxydodecyl acrylate, 12-hydroxydodecyl methacrylate, or 12-hydroxydodecyl decyl acrylate, or a combination of these compounds. The hydrophilic monomer for the hydrophilic monomer group may be an acrylate or methacrylate from the above group. It is preferably selected from acrylate monomers. Preferred hydrophilic monomers are n-hydroxyalkyl groups having 1 to 4 carbon atoms in the alkyl chain. n-Hydroxyalkyl acrylates and n-hydroxyalkyl methacrylates. 2-Hydroxyethyl methacrylate (HEMA), Hydroxyethyl acrylate ( HEA), or a mixture of these monomers, is particularly preferred for the composition according to the invention. is preferably selected.
[0057] The present invention therefore furthermore relates to a composition as described above or preferably as described below. At least one hydrophilic monomer therein is 3-hydroxypropyl methacrylate. , 3-hydroxypropyl acrylate, 2-hydroxyethyl methacrylate, 2- Hydroxyethyl acrylate, 4-hydroxybutyl methacrylate, 4-hydroxy Butyl acrylate, glyceryl methacrylate, glyceryl acrylate, acrylic amide, N-vinylpyrrolidone, 6-hydroxyhexyl methacrylate, 6-hydroxy Hexyl acrylate, 18-hydroxyoctadecyl methacrylate, 18-hydroxy Cioctadecyl acrylate, 11-hydroxyundecyl methacrylate, 11-hydroxy 12-Hydroxyundecyl acrylate, 12-hydroxydodecyl methacrylate, 12-hydroxy ethyl oxydodecyl acrylate, ethylene glycol phenyl ether acrylate, ethylene ethylene glycol phenyl ether methacrylate, or a combination of these compounds are selected.
[0058] Besides one or more compounds of formula (1), (2), (3), (4) or compounds (M-1) to (M-63) as described above or preferably as described above, the composition according to the invention comprises a hydrophilic monomer or a combination of hydrophilic monomers as described above, wherein of all compounds of formula (1) or of the preferred compounds of formula (1) in total, relative to the sum of all hydrophilic monomers Rumo The ratio of the fluorine atom to the fluorine atom is preferably 1:0.56 to 1:1.2, and particularly preferably 1:0.6 to 1:1.
[0059] As described above or preferably as described above, one or more of the formulas (1), (2), (3), (4) In addition to the compounds (M-1) to (M-63) and the hydrophilic monomer, As shown above, in the above molar ratio, the composition according to the present invention does not conform to formula (1). at least one further non-hydrophilic monomer, and / or at least one blue absorbing agent. , may be provided.
[0060] The present invention therefore further relates to a compound as described above or preferably as described above, which has the formula (1), or at least one further compound not conforming to the preferred embodiments of the compound of formula (1). The present invention relates to a composition comprising a non-hydrophilic monomer. The present invention relates to a method for producing a medicament for a medicament for use in ... The present invention relates to a composition comprising at least one blue absorbing agent.
[0061] Suitable blue absorbers are materials that exhibit absorption in the blue wavelength region of visible light. or blue absorbing, similar to methacrylates, available as further monomers during polymerization Suitable blue absorbing agents are preferably selected. 124. A particularly preferred blue absorber is N-2-[3-(2'-methylphenyl)- The compound is (4-hydroxyphenylazo)-ethylmethylacrylamide. When the material is used for the production of ophthalmic products, the polymerized composition is exposed to ultraviolet light as well as to filter out short-wavelength visible light, thus better protecting the retina. For this reason they can be added to the compositions according to the invention.
[0062] Non-hydrophilic monomers or compounds of formula (1) not conforming to the preferred embodiments of formula (1) The non-hydrophilic monomers provide further optimization of the composition and the corresponding resulting copolymers. For optimization, unsubstituted or substituted aliphatic groups and / or unsubstituted or substituted aromatic groups and / or sulfide bonds and and / or fluorinated groups. Substituted aliphatic or aromatic groups are selected. If present, they are preferably substituted by at least one substituent R#, where R# in each occurrence is independently F, Cl, Br, I, or a 1-20 carbon atom. A linear or branched alkyl group having 1 to 20 carbon atoms. Alkoxy groups, partially or fully halogenated alkyl groups having 1 to 20 carbon atoms. Chain or branched alkyl groups, partially or fully halogenated, having 1 to 20 carbon atoms substituted linear or branched alkoxy groups, cycloalkyl groups having 5 to 8 carbon atoms an arylalkoxy group having 7 to 20 carbon atoms or an arylalkoxy group having 5 to 40 ring atoms; represents an aryl or heteroaryl group, wherein The aryl group as part of an arylalkoxy group is a straight-chain or aryl group having 1 to 12 carbon atoms. or branched alkyl group or cycloalkyl group having 5 to 8 carbon atoms. It may be possible.
[0063] Examples of non-hydrophilic monomers are: n-butyl acrylate, n-butyl Methacrylate, ethyl methacrylate, ethyl acrylate, methyl methacrylate, Methyl acrylate, n-propyl methacrylate, n-propyl acrylate, isopropyl n-propyl methacrylate, isopropyl acrylate, n-pentyl acrylate, s-butyl methacrylate, isopentyl methacrylate, isopentyl acrylate, Butyl acrylate, s-butyl methacrylate, n-hexyl acrylate, n-hexyl s-pentyl acrylate, s-pentyl methacrylate, isohexyl xyl acrylate, isohexyl methacrylate, n-octyl acrylate, n-octyl n-octyl methacrylate, isooctyl acrylate, isooctyl methacrylate Nonyl acrylate, n-nonyl methacrylate, n-decyl acrylate, n-decyl Methacrylate, n-undecyl acrylate, n-undecyl methacrylate, n-do n-Decyl acrylate, n-Dodecyl methacrylate, n-Octadecyl acrylate, n -Octadecyl methacrylate, 2-ethylhexyl acrylate, 2-ethylhexyl Methacrylate, n-dodecyl acrylate, n-dodecyl methacrylate, n-tride Sil acrylate, n-tridecyl methacrylate, n-tetradecyl acrylate, n -Tetradecyl methacrylate, n-pentadecyl acrylate, n-pentadecyl meth Acrylate, n-Hexadecyl acrylate, n-Hexadecyl methacrylate, 2,2 -Dimethylpropyl acrylate, 2,2-dimethylpropyl methacrylate, trimethyl Trimethylcyclohexyl acrylate, Trimethylcyclohexyl methacrylate, Isobutyl Acrylate, isobutyl methacrylate, 2-(4-bromophenyl)ethyl methacrylate 4-phenylbutyl methacrylate, 4-methylphenyl methacrylate, Nyl methacrylate, 4-methylphenyl acrylate, benzyl acrylate, benzyl 2-benzyloxyethyl methacrylate, 3-benzyloxypropyl methacrylate Pyrmethacrylate, Phenylethylacrylate, Phenylethylmethacrylate, 3 -Phenylpropyl methacrylate, 2-phenoxyethyl acrylate, 2-benzyl Oxyethyl acrylate, 3-phenylpropyl acrylate, 4-methylbenzyl acrylate Acrylate, Phenyl acrylate, 2-(phenylthio)ethyl methacrylate, 4- Phenylbutyl acrylate, 5-phenylpentyl acrylate, 3-benzyloxy Propyl acrylate, 2-(phenylthio)propyl acrylate, 2-(phenylthio)propyl acrylate Ethyl acrylate, 4-phenylbutyl acrylate, 4-methylbenzyl methacrylate acrylate, 2-(2-methylphenyl)ethyl acrylate, 2-(2-methylphenyl ) ethyl methacrylate, 2-(3-methylphenyl)ethyl acrylate, 2-(3- 2-(4-methylphenyl)ethyl acrylate methacrylate, 2-(4-methylphenyl)ethyl methacrylate, 2-(4-propylphenyl) Ethyl acrylate, 2-(4-propylphenyl)ethyl methacrylate, 2-(4- (1-methylethyl)phenyl)ethyl acrylate, 2-(4-(1-methylethyl) 2-(4-methoxyphenyl)ethyl methacrylate , 2-(4-methoxyphenyl)ethyl acrylate, 2-(4-cyclohexylphenyl 2-(4-cyclohexylphenyl)ethyl acrylate, 2-(4-cyclohexylphenyl)ethyl methacrylate, 2-(4-chlorophenyl)ethyl methacrylate, 2-(4-chlorophenyl)ethyl Acrylate, 2-(3-chlorophenyl)ethyl methacrylate, 2-(3-chlorophenyl)ethyl 2-(2-chlorophenyl)ethyl acrylate, 2-(2-chlorophenyl)ethyl methacrylate, (2-Chlorophenyl)ethyl acrylate, 2-(4-bromophenyl)ethyl acrylate 2-(4-phenylphenyl)ethyl methacrylate, 2-ethyl(4-phenyl 2-ethyl(3-phenylphenyl)acrylate, 2-ethyl(3-phenylphenyl)methacrylate, 2- Ethyl(3-phenylphenyl)acrylate, 2-ethyl(4-benzylphenyl)methacrylate 2-ethyl(4-benzylphenyl)acrylate, 2-ethyl(phenyl 3-benzyloxypropyl acrylate, 2-ethyl[2-ethyl 2-Ethoxy(benzyloxy)]acrylate, 2-Ethyl[2-ethoxy(benzyloxy)]acrylate )]methacrylate, pentafluorophenyl methacrylate, heptadecafluorodecyl dodecafluoroheptyl methacrylate, heptadecafluorodecyl methacrylate Acrylate, Trifluoroethyl Methacrylate, Octafluoropentyl Methacrylate acrylate, hexafluorobutyl methacrylate, octafluoropentyl acrylate, Trifluoroethyl acrylate, heptafluorobutyl acrylate, tetrafluoropropane propyl methacrylate, hexafluorobutyl acrylate, pentafluorophenyl a Acrylate, hexafluoro-isopropyl methacrylate.
[0064] Preferred non-hydrophilic monomers are phenoxyalkyl groups having a chain length of 8 to 20 carbon atoms. Acrylates, phenoxyalkyl methacrylates, alkyl acrylates, and alkoxyalkyl methacrylates. alkyl methacrylates, and alkylene or alkyloxy groups having a chain length of 1 to 8 carbon atoms. phenyl alkoxyacrylate, ... Alkoxy methacrylates, phenyl alkoxy alkyl acrylates, and phenyl It is an alkoxyalkyl methacrylate.
[0065] n-Octadecyl methacrylate (C18MA) or 2-phenoxyethyl acrylate ethylenediaminetetraacetate (EGPEA), or a combination of these compounds as non-hydrophilic monomers. Particularly preferably selected are the synonymous names for 2-phenylethyl acrylate: Ethylene glycol phenyl ether acrylate.
[0066] The present invention further relates to a composition as described above or preferably as described herein, wherein at least one non-hydrophilic monomer is selected from the following: n-butyl acrylamide; acrylate, n-butyl methacrylate, ethyl methacrylate, ethyl acrylate, methyl Methacrylate, methyl acrylate, n-propyl methacrylate, n-propyl acrylate acrylate, isopropyl methacrylate, isopropyl acrylate, n-pentyl acrylate acrylate, n-pentyl methacrylate, isopentyl methacrylate, isopentyl a Acrylate, s-butyl acrylate, s-butyl methacrylate, n-hexyl acrylate acrylate, n-hexyl methacrylate, s-pentyl acrylate, s-pentyl methacrylate acrylate, isohexyl acrylate, isohexyl methacrylate, n-octyl acrylate acrylate, n-octyl methacrylate, isooctyl acrylate, isooctyl methacrylate acrylate, n-nonyl acrylate, n-nonyl methacrylate, n-decyl acrylate acrylate, n-decyl methacrylate, n-undecyl acrylate, n-undecyl methacrylate Lylate, n-dodecyl acrylate, n-dodecyl methacrylate, n-octadecyl Acrylate, n-octadecyl methacrylate, 2-ethylhexyl acrylate, 2 -Ethylhexyl methacrylate, n-dodecyl acrylate, n-dodecyl methacrylate acrylate, n-tridecyl acrylate, n-tridecyl methacrylate, n-tetradecyl Acrylate, n-tetradecyl methacrylate, n-pentadecyl acrylate, n- Pentadecyl methacrylate, n-hexadecyl acrylate, n-hexadecyl methacrylate 2,2-Dimethylpropyl acrylate, 2,2-Dimethylpropyl methacrylate acrylate, trimethylcyclohexyl acrylate, trimethylcyclohexyl methacrylate acrylate, isobutyl acrylate, isobutyl methacrylate, 2-(4-bromophenyl ) Ethyl methacrylate, 4-phenylbutyl methacrylate, 4-methylphenyl methacrylate Acrylate, Phenyl methacrylate, 4-methylphenyl acrylate, Benzyl acrylate benzyl methacrylate, 2-benzyloxyethyl methacrylate, 3-benzyloxyethyl methacrylate benzyloxypropyl methacrylate, phenylethyl acrylate, phenylethyl methacrylate Methacrylate, 3-phenylpropyl methacrylate, 2-phenoxyethyl acrylate , 2-benzyloxyethyl acrylate, 3-phenylpropyl acrylate, 4- Methylbenzyl acrylate, Phenyl acrylate, 2-(phenylthio)ethyl methacrylate Acrylate, 4-phenylbutyl acrylate, 5-phenylpentyl acrylate, 3 -benzyloxypropyl acrylate, 2-(phenylthio)propyl acrylate, 2-(Phenylthio)ethyl acrylate, 4-Phenylbutyl acrylate, 4-Methionyl benzyl methacrylate, 2-(2-methylphenyl)ethyl acrylate, 2-(2 -Methylphenyl)ethyl methacrylate, 2-(3-methylphenyl)ethyl acryl methacrylate, 2-(3-methylphenyl)ethyl methacrylate,
[0067] 2-(4-methylphenyl)ethyl acrylate, 2-(4-methylphenyl)ethyl methacrylate Thacryllate, 2-(4-propylphenyl)ethyl acrylate, 2-(4-propyl 2-(4-(1-methylethyl)phenyl)ethyl acrylate Acrylate, 2-(4-(1-methylethyl)phenyl)ethyl methacrylate, 2-( 4-Methoxyphenyl)ethyl methacrylate, 2-(4-Methoxyphenyl)ethyl a Acrylate, 2-(4-cyclohexylphenyl)ethyl acrylate, 2-(4-cyclohexylphenyl)ethyl acrylate 2-(4-chlorophenyl)ethyl methacrylate acrylate, 2-(4-chlorophenyl)ethyl acrylate, 2-(3-chlorophenyl )ethyl methacrylate, 2-(3-chlorophenyl)ethyl acrylate, 2-(2- 2-(2-chlorophenyl)ethyl acrylate 2-(4-bromophenyl)ethyl acrylate, 2-(4-phenylphenyl)ethyl acrylate ethyl methacrylate,
[0068] 2-Ethyl(4-phenylphenyl)acrylate, 2-Ethyl(3-phenylphenyl)acrylate ) methacrylate, 2-ethyl(3-phenylphenyl)acrylate, 2-ethyl(4 -benzylphenyl)methacrylate, 2-ethyl(4-benzylphenyl)acrylate , 2-ethyl(phenylthio)acrylate, 3-benzyloxypropyl acrylate 2-Ethyl [2-ethoxy (benzyloxy)] acrylate, 2-Ethyl [2-ethoxy (benzyloxy)] acrylate (benzyloxy)] methacrylate, pentafluorophenyl methacrylate, Heptadecafluorodecyl methacrylate, dodecafluoroheptyl methacrylate, Putadecafluorodecyl acrylate, Trifluoroethyl methacrylate, Octaful Oropentyl methacrylate, hexafluorobutyl methacrylate, octafluoropentyl butyl acrylate, trifluoroethyl acrylate, heptafluorobutyl acrylate acrylate, tetrafluoropropyl methacrylate, hexafluorobutyl acrylate, hexafluorophenyl acrylate, hexafluoroisopropyl methacrylate, or a combination of these compounds.
[0069] As described above, the composition according to the present invention comprises at least one crosslinking agent and at least one It also contains a UV absorber. That is, it is both a crosslinker and a UV absorber. It is also possible here for a substance to have both properties. The crosslinker is a monomer that contains at least two polymerizable groups. The crosslinking agent preferably has one polymerizable group. The crosslinking agent preferably has a functional group capable of coordinating water, e.g. Crosslinkers functionalized in this manner may also optionally contain OH or NH groups. are preferred hydrophilic monomers within the meaning of the invention and can be combined with the above hydrophilic monomers and is preferably used.
[0070] Examples of cross-linking agents are: Paradivinylbenzene, Allyl acrylate, Ethylene glycol divinyl ether, Di Vinyl sulfone, allyl methacrylate, N,N'-methylene-bis-acrylamide, Ethylene glycol diacrylate, N,N'-methylene-bis-methacrylamide, 1 ,3-Propanediol diacrylate, 2,3-Propanediol diacrylate, 1 ,4-Butanediol diacrylate, 1,3-Butanediol diacrylate, 1,5 -Pentanediol diacrylate, 1,6-Hexanediol diacrylate, 1,7 -Heptanediol diacrylate, 1,8-Octanediol diacrylate, 1,9 -Nonanediol diacrylate, 1,10-Decanediol diacrylate, 1,11 -Undecanediol diacrylate, 1,12-Dodecanediol diacrylate, 1 ,13-Tridecanediol diacrylate, 1,14-Tetradecanediol diacrylate acrylate, 1,15-pentadecanediol diacrylate, 1,16-hexadecanedio 1,17-heptadecanediol diacrylate, 1,18-octadecanediol diacrylate Tadecanediol diacrylate, 1,19-nonadecanediol diacrylate, 1, 20-Eicosanediol diacrylate, 1,21-Eicosanediol diacrylate 1,22-Docosanediol diacrylate, 1,23-Tricosanediol diacrylate Acrylate, 1,24-tetracosanediol diacrylate, ethylene glycol diacrylate Methacrylate, N,N'-dihydroxyethylenebisacrylamide, thiodiethylene Glycol diacrylate, 1,3-propanediol dimethacrylate, 2,3-propanediol Pandiol dimethacrylate, 1,3-butanediol dimethacrylate, 1,4-butanediol dimethacrylate Tandiol dimethacrylate, 1,5-pentanediol dimethacrylate, 1,6- Hexanediol dimethacrylate, 1,7-heptanediol dimethacrylate, 1, 8-Octanediol dimethacrylate, 1,9-Nonanediol dimethacrylate, 1 ,10-Decanediol dimethacrylate, 1,11-Undecanediol dimethacrylate 1,12-Dodecanediol dimethacrylate, 1,13-Tridecanediol dimethacrylate Methacrylate, 1,14-tetradecanediol dimethacrylate, 1,15-penta Decanediol dimethacrylate, 1,16-hexadecanediol dimethacrylate, 1,17-heptadecanediol dimethacrylate, 1,18-octadecanediol dimethacrylate Methacrylate, 1,19-nonadecanediol dimethacrylate, 1,20-eicosapentaenoic acid Hexanediol dimethacrylate, 1,21-heneicosanediol dimethacrylate, 1 ,22-Docosanediol dimethacrylate, 1,23-Tricosanediol dimethacrylate 1,24-Tetracosanediol dimethacrylate, 2-(acryloyloxy) ) ethyl methacrylate, 2-(acryloyloxy)propyl methacrylate, 3-( 4-(acryloyloxy)propyl methacrylate, 4-(acryloyloxy)butyl methacrylate Acrylate, 5-(acryloyloxy)pentyl methacrylate, 6-(acryloyl 7-(Acryloyloxy)hexyl methacrylate, 7-(Acryloyloxy)heptyl methacrylate , 8-(acryloyloxy)octyl methacrylate, 9-(acryloyloxy)no 10-(acryloyloxy)decyl methacrylate, 11-(acryloyloxy)decyl methacrylate 12-(acryloyloxy)undecyl methacrylate, 12-(acryloyloxy)dodecyl Methacrylate, 13-(acryloyloxy)tridecyl methacrylate, 14-(acryloyloxy)tridecyl methacrylate 15-(acryloyloxy)tetradecyl methacrylate, 15-(acryloyloxy)penta Decyl methacrylate, 16-(acryloyloxy)hexadecyl methacrylate, 1 7-(Acryloyloxy)-heptadecyl methacrylate, 18-(Acryloyloxy) 19-(acryloyloxy)nonadecylamethyl methacrylate 20-(acryloyloxy)eicosanyl methacrylate, 21-(acryloyloxy)eicosanyl methacrylate 22-(Acryloyloxy)heneicosanyl methacrylate, 22-(Acryloyloxy)docosanyl Methacrylate, 23-(acryloyloxy)tricosyl methacrylate, 24-( Acryloyloxy)tetracosanyl methacrylate, neopentyl glycol diacrylate Di(ethylene glycol) diacrylate, N,N'-hexamethylene bis(acrylate) arylamide, thiodiethylene glycol diacrylate, thiodiethylene glycol Thacryllate, Neopentyl glycol dimethacrylate, Diethylene glycol dimethacrylate Acrylate, Diallyl Phthalate, Triallyl Cyanurate, Glyceryl 1,3-Dimethacrylate Acrylate, N,N'-hexamethylene bismetho-acrylamide, tri(ethylene glycol) dimethacrylate, tri(ethylene glycol) dimethacrylate, tetra(ethylene Tetra(ethylene glycol) diacrylate, tetra(ethylene glycol) dimethacrylate, Penta(ethylene glycol) diacrylate, Penta(ethylene glycol) dimethacrylate acrylate, hexa(ethylene glycol) diacrylate, hexa(ethylene glycol) Dimethacrylate, Poly(ethylene glycol) dimethacrylate, Poly(ethylene glycol) Cole) diacrylate.
[0071] The preferred crosslinking agent is ethylene glycol dimethyl acrylate, 1,3-propanediol. 2,3-Propanediol diacrylate, 1,4-Butanediol diacrylate 1,3-Butanediol Diacrylate, 1,5-Pentanediol Diacrylate, 1,6-Hexanediol Diacrylate, 1,7-Heptanediol Diacrylate, 1,8-Octanediol Diacrylate, 1,9-Nonanediol Diacrylate acrylate, 1,10-decanediol diacrylate, 1,11-undecanediol 1,12-Dodecanediol Diacrylate, 1,13-Tridecanediol Diacrylate Diol diacrylate, 1,14-tetradecanediol diacrylate, 1,15- Pentadecanediol diacrylate, 1,16-hexadecanediol diacrylate , 1,17-heptadecanediol diacrylate, 1,18-octadecanediol diacrylate Acrylate, 1,19-nonadecanediol diacrylate, 1,20-eicosandiol 1,21-Henneicosanediol diacrylate, 1,22- Docosanediol diacrylate, 1,23-tricosanediol diacrylate, 1, 24-Tetracosanordiol diacrylate, 1,3-propanediol dimethacrylate 2,3-propanediol dimethacrylate, 1,3-butanediol dimethacrylate 1,4-Butanediol dimethacrylate, 1,5-Pentanediol dimethacrylate 1,6-Hexanediol Dimethacrylate, 1,7-Heptanediol Dimethacrylate acrylate, 1,8-octanediol dimethacrylate, 1,9-nonanediol dimethacrylate Tacrylate, 1,10-Decanediol Dimethacrylate, 1,11-Undecanediol dimethacrylate, 1,12-dodecanediol dimethacrylate, 1,13-tri Decanediol dimethacrylate, 1,14-tetradecanediol dimethacrylate, 1,15-Pentadecanediol dimethacrylate, 1,16-Hexadecanediol dimethacrylate Methacrylate, 1,17-heptadecanediol dimethacrylate, 1,18-octadecane Decanediol dimethacrylate, 1,19-Nonadecanediol dimethacrylate, 1 ,20-Eicosanediol dimethacrylate, 1,21-Eicosanediol dimethacrylate Tacrylate, 1,22-Docosanediol Dimethacrylate, 1,23-Tricosandiol ol dimethacrylate, 1,24-tetracosanediol dimethacrylate, glyceryl The main compounds are aryl 1,3-dimethacrylate, and diallyl phthalate.
[0072] Glyceryl 1,3-dimethacrylate (GDMA), Ethylene glycol dimethyl acrylate Dimethacrylate (EGDMA), Penta(ethylene glycol) dimethacrylate, Hexa(ethylene ethylene glycol) dimethacrylate, or a combination of these compounds is It is therefore very particularly preferably selected.
[0073] In particular, the preferred crosslinking agent is ethylene glycol dimethyl acrylate, 1,3-propanediol. Pandiol diacrylate, 1,4-butanediol dimethacrylate, 1,6-hexadecyl Sandiol dimethacrylate, 1,18-octadecanediol diacrylate, 1, 18-Octadecanediol Dimethacrylate, Glyceryl 1,3-Dimethacrylate and and diallyl phthalate. Glyceryl 1,3-dimethacrylate (GDMA), ethyl Dimethyl acrylate (EGDMA), penta(ethylene glycol) diacrylate Methacrylate, Hexa(ethylene glycol) dimethacrylate, 1,18-octadeca Candiol diacrylate, 1,18-octadecanediol dimethacrylate, 18 -(Acryloyloxy)octadecyl methacrylate, 1-acryloyl-18-octadecyl Tadecanediol dimethacrylate, or a combination of these compounds according to the invention is very particularly preferably selected.
[0074] Thus, as described above and preferably below, the present invention further relates to a composition. The crosslinking agent therein is selected from the following group: para-divinylbenzene, allyl acrylamide ester, ethylene glycol divinyl ether, divinyl sulfone, allyl methacrylate , N,N'-methylene-bis-acrylamide, ethylene glycol diacrylate, N ,N'-Methylene-bis-methacrylamide, 1,3-propanediol diacrylate , 2,3-propanediol diacrylate, 1,4-butanediol diacrylate, 1,3-Butanediol diacrylate, 1,5-Pentanediol diacrylate, 1 ,6-Hexanediol diacrylate, 1,7-Heptanediol diacrylate, 1 ,8-Octanediol diacrylate, 1,9-Nonanediol diacrylate, 1, 10-Decanediol diacrylate, 1,11-Undecanediol diacrylate, 1,12-Dodecanediol Diacrylate, 1,13-Tridecanediol Diacrylate 1,14-Tetradecanediol diacrylate, 1,15-Pentadecanediol diacrylate 1,16-Hexadecanediol diacrylate, 1,17-Heptadecanediol diacrylate Decanediol diacrylate, 1,18-octadecanediol diacrylate, 1, 19-Nonadecanediol diacrylate, 1,20-Eicosanediol diacrylate acrylate, 1,21-heneicosanediol diacrylate, 1,22-docosanediol Diacrylate, 1,23-Tricosadiol Diacrylate, 1,24-Tetracosa Diol diacrylate, Ethylene glycol dimethacrylate, N,N'-dihydro Thiodiethylene glycol diacrylate, 1,3- Propanediol dimethacrylate, 2,3-propanediol dimethacrylate, 1, 3-Butanediol dimethacrylate, 1,4-Butanediol dimethacrylate, 1, 5-Pentanediol dimethacrylate, 1,6-Hexanediol dimethacrylate, 1,7-heptanediol dimethacrylate, 1,8-octanediol dimethacrylate 1,9-nonanediol dimethacrylate, 1,10-decanediol dimethacrylate 1,11-Undecanediol Dimethacrylate, 1,12-Dodecanediol Dimethacrylate Methacrylate, 1,13-tridecanediol dimethacrylate, 1,14-tetradecanediol Candiol dimethacrylate, 1,15-pentadecanediol dimethacrylate, 1 ,16-Hexadecanediol dimethacrylate, 1,17-Heptadecanediol dimethacrylate Tacrylate, 1,18-Octadecanediol Dimethacrylate, 1,19-Nonadeca 1,20-Eicosanediol dimethacrylate, 1,2 1-Heneneicosanediol dimethacrylate, 1,22-Docosanediol dimethacrylate 1,23-Tricosanediol dimethacrylate, 1,24-Tricosanediol dimethacrylate dimethacrylate, 2-(acryloyloxy)ethyl methacrylate, 2-(acryloyloxy)ethyl methacrylate 3-(acryloyloxy)propyl methacrylate, 3-(acryloyloxy)propyl methacrylate acrylate, 4-(acryloyloxy)butyl methacrylate, 5-(acryloyloxy) 6-(acryloyloxy)hexyl methacrylate, 7 -(Acryloyloxy)heptyl methacrylate, 8-(Acryloyloxy)octyl methacrylate, 9-(acryloyloxy)nonyl methacrylate, 10-(acryloyloxy)nonyl methacrylate 11-(acryloyloxy)decyl methacrylate, 11-(acryloyloxy)undecyl methacrylate acrylate, 12-(acryloyloxy)dodecyl methacrylate, 13-(acryloyloxy) 14-(acryloyloxy)tetradecyl methacrylate, 14-(acryloyloxy)tetradecyl methacrylate acrylate, 15-(acryloyloxy)pentadecyl methacrylate, 16-(acryloyloxy)pentadecyl methacrylate 17-(acryloyloxy)-hexadecyl methacrylate, 17-(acryloyloxy)-hepta Decyl methacrylate, 18-(acryloyloxy)octadecyl methacrylate, 1 9-(Acryloyloxy)nonadecyl methacrylate, 20-(Acryloyloxy) Eicosanyl methacrylate, 21-(acryloyloxy)heneicosanyl methacrylate 22-(acryloyloxy)-docosanyl methacrylate, 23-(acryloyloxy)-docosanyl methacrylate 24-(acryloyloxy)tricosaniyl methacrylate, 24-(acryloyloxy)tetracosanyl dimethacrylate, neopentyl glycol diacrylate, di(ethylene glycol) Diacrylate, N,N'-hexamethylenebisacrylamide, thiodiethyleneglycol Dimethacrylate, Thiodiethylene glycol dimethacrylate, Neopentyl glycol Diethylene glycol dimethacrylate, Diethylene glycol dimethacrylate, Diallyl phthalate, Triallyl cyanurate, glyceryl 1,3-dimethacrylate, N,N'-hexamethyl ethylenebismethacrylamide, tri(ethylene glycol) diacrylate, tri(ethylene Tetra(ethylene glycol) dimethacrylate, tetra(ethylene glycol) diacrylate, tetra Penta(ethylene glycol) dimethacrylate, penta(ethylene glycol) diacrylate acrylate, penta(ethylene glycol) dimethacrylate, hexa(ethylene glycol) Diacrylate, hexa(ethylene glycol) dimethacrylate, poly(ethylene glycol) poly(ethylene glycol) dimethacrylate, poly(ethylene glycol) diacrylate, or or combination of compounds. The UV absorbers selected according to the invention contain polymerizable groups and have strong absorption in the UV range. It is a molecule with a yield.
[0075] Examples of UV absorbers are: 3-(3-(tertiary butyl)-4-hydroxy-5-(5-methoxy-2H-benzo[d] -1,2,3-triazol-2-yl)-phenoxy)propyl methacrylate, 2- (2-Hydroxy-5-vinylphenyl)-2H-benzo-triazole, Allyl-2- Hydroxybenzophenone, 2-allyl-6-(2H-benzotriazol-2-yl) -p-cresol, 4-methacryloxy-2-hydroxybenzophenone, 2-(2' -Hydroxy-3'-methallyl-5'-methylphenyl)benzotriazole, 2-Hydroxy 4-Acryloylethoxy-2-hydroxybenzophenone, 4-Acryloylethoxy-2-hydroxybenzophenone Hydroxybenzophenone, 2-[3-(2H-benzotriazol-2-yl)-4-hydroxybenzophenone 2-(2'-hydroxy-5'-methacrylate)ethyl methacrylate Amidophenyl)-5-methoxybenzotriazole, 2-(2'-hydroxy-5'- Methacrylamidophenyl)-5-chlorobenzotriazole, 2-(2'-hydroxy -5'-Methacryloxypropylphenyl)benzotriazole, 2-(2'-hydroxy 5'-Methacryloylpropyl-3'-tert-butyl-phenyl)-5-methoxy- 2H-Benzotriazole, 2-(3-(tertiary butyl)-4-hydroxy-5-(5-methyl) Tox-2H-benzo[d]-1,2,3-triazol-2-yl)phenoxy)ethyl methacrylate, 2-[3'-tert-butyl-2'-hydroxy-5'-(3''-methyl 2-(2'-tacryloyloxypropyl)phenyl]-5-chlorobenzotriazole -Hydroxy-3'-tert-butyl-5'-[3'-methacryloyloxypropoxy] phenyl}-5-methoxy-2H-benzotriazole, 2-[3'-tert-butyl-5' -(3''-dimethylvinylsilylpropoxy)-2'-hydroxyphenyl]-5-methyl Toxobenzotriazole, 2-(tert-butyl)-6-(5-chloro-2H-benzo[d ]-1,2,3-triazol-2-yl)-4-vinylphenol, 2-(2H-1, 2,3-Benzotriazol-2-yl)-4-methyl-6-(2-methylprop-2-yl) (enyl)phenol, 2-(3-acetyl-2-aminophenoxy)ethyl methacrylate , 2-(4-benzoyl-3-hydroxyphenoxy)ethyl acrylate. Preferred UV absorbers are phenyltriazoles or benzotriazoles, Most commonly, the methacrylates and acrylates of benzotriazoles.
[0076] A particularly preferred UV absorber is 2-[3-(2H-benzotriazol-2-yl) -4-hydroxyphenyl]ethyl methacrylate or 3-(3-(tertiary butyl)-4 -Hydroxy-5-(5-methoxy-2H-benzo[d]-1,2,3-triazole- 2-yl)phenoxy)propyl methacrylate.
[0077] Thus, as described above and preferably below, the present invention further relates to a composition. , wherein the ultraviolet absorber is selected from the following group: 3-(3-(tertiary butyl)-4- Hydroxy-5-(5-methoxy-2H-benzo[d]-1,2,3-triazole-2 -yl)-phenoxy)propyl methacrylate, 2-(2-hydroxy-5-vinyl phenyl)-2H-benzo-triazole, allyl-2-hydroxybenzophenone, 2- Allyl-6-(2H-benzotriazol-2-yl)-p-cresol, 4-methacryloyl Peroxy-2-hydroxybenzophenone, 2-(2'-hydroxy-3'-methallyl- 5'-Methylphenyl)benzotriazole, 2-hydroxy-4-methacryloxy Dibenzophenone, 4-acryloylethoxy-2-hydroxybenzophenone, 2-[ 3-(2H-benzotriazol-2-yl)-4-hydroxyphenyl]ethylmethacrylate Lyrato, 2-(2'-hydroxy-5'-methacrylamidophenyl)-5-methoxy Benzotriazole, 2-(2'-hydroxy-5'-methacrylamidophenyl)-5 -Chlorobenzotriazole, 2-(2'-hydroxy-5'-methacryloxypropyl phenyl)benzotriazole, 2-(2'-hydroxy-5'-methacryloxypropionyl 2-(3'-tert-butyl-phenyl)-5-methoxy-2H-benzotriazole, (3-(tertiary butyl)-4-hydroxy-5-(5-methoxy-2H-benzo[d]-1 ,2,3-triazol-2-yl)phenoxy)ethyl methacrylate, 2-[3'- tert-butyl-2'-hydroxy-5'-(3''-methacryloxypropyl) phenyl]-5-chlorobenzotriazole, 2-{2'-hydroxy-3'-tertiary-buty {5'-[3'-methacryloxyloxypropoxy]phenyl}-5-methoxy-2H -benzotriazole,
[0078] 2[3'-tert-butyl-5'-(3''-dimethylvinylsilylpropoxy)-2'-butyl hydroxyphenyl]-5-methoxybenzotriazole, 2-(tert-butyl)-6-(5 -Chloro-2H-benzo[d]-1,2,3-triazol-2-yl)-4-vinyl Enol, 2-(2H-1,2,3-benzotriazol-2-yl)-4-methyl-6 -(2-methylprop-2-enyl)phenol, 2-(3-acetyl-2-aminophenol 2-(4-benzoyl-3-hydroxyphenoxy)ethyl methacrylate ethyl acrylate, or a combination of these compounds. The present invention relates to a composition as described above or preferably as described above, characterized in that it comprises Pertaining to and about something: 1 molar equivalent of a compound of formula (1) as described above, or a preferred compound of formula (1), or 1 mole of the sum of all compounds of formula (1) as described above or preferably as described above. equivalent; 0.51 to 1.24 molar equivalents of a hydrophilic monomer as described above or preferably as described; 0 to 1 of a non-hydrophilic monomer not conforming to formula (1) as described above or preferably as described above. .0 molar equivalents; 0.04 to 0.5 molar equivalents of crosslinker as described above or preferably as described above and 0.005 to 0.05 molar equivalents of UV absorber as described above or preferably as described above. The present invention relates to a composition as described above or preferably as described above, characterized in that it comprises Pertaining to and about something: 1 molar equivalent of a compound of formula (1) as described above, or a preferred compound of formula (1), or 1 mole of the sum of all compounds of formula (1) as described above or preferably as described above. equivalent; 0.51 to 1.24 molar equivalents of a hydrophilic monomer as described above or preferably as described; 0 to 0 of a non-hydrophilic monomer not conforming to formula (1) as described above or preferably as described above. .2 molar equivalents; 0.05 to 0.5 molar equivalents of crosslinker as described above or preferably as described above and 0.005 to 0.05 molar equivalents of UV absorber as described above or preferably as described above. The present invention relates to a composition as described above or preferably as described above, characterized in that it comprises Pertaining to and about something: 1 molar equivalent of a compound of formula (1) as described above, or a preferred compound of formula (1), or 1 mole of the sum of all compounds of formula (1) as described above or preferably as described above. equivalent; 0.51 to 1.24 molar equivalents of a hydrophilic monomer as described above or preferably as described; 0.0% of non-hydrophilic monomers not conforming to formula (1) as described above or preferably as described above. 5 to 1.0 molar equivalents; 0.04 to 0.5 molar equivalents of crosslinker as described above or preferably as described above and 0.005 to 0.05 molar equivalents of UV absorber as described above or preferably as described above. The present invention relates to a composition as described above or preferably as described above, characterized in that it comprises Pertaining to and about something: 1 molar equivalent of a compound of formula (1) as described above, or a preferred compound of formula (1), or 1 mole of the sum of all compounds of formula (1) as described above or preferably as described above. equivalent; 0.51 to 1.24 molar equivalents of a hydrophilic monomer as described above or preferably as described; 0.0% of non-hydrophilic monomers not conforming to formula (1) as described above or preferably as described above. 5 to 0.2 molar equivalents; 0.05 to 0.5 molar equivalents of crosslinker as described above or preferably as described above and 0.005 to 0.05 molar equivalents of UV absorber as described above or preferably as described above.
[0079] In an embodiment of the composition according to the present invention, as described above, the compound represented by formula (1), (2), (3), Compound (4), or preferred compounds, such as (M-1) to (M 63), or In addition to 1 molar equivalent of the total of all compounds of the type, As described above, 0.56 to 1.2 molar equivalents of all hydrophilic monomers, or preferably It is preferred if it comprises 0.6 to 1 molar equivalent.
[0080] In an embodiment of the composition according to the present invention, as described above, the compound represented by formula (1), (2), (3), Compound (4), or preferred compounds, such as (M-1) to (M-63), or In addition to 1 molar equivalent of the total of all compounds of the type, As described above, it is preferred that the composition comprises 0.1 to 0.2 molar equivalents of a non-hydrophilic monomer. stomach.
[0081] In an embodiment of the composition according to the present invention, as described above, the compound represented by formula (1), (2), (3), Compound (4), or preferred compounds, such as (M-1) to (M-63), or In addition to 1 molar equivalent of the total of all compounds of the type, As mentioned above, it is preferable if 0.01 to 0.03 molar equivalents of the crosslinker are provided.
[0082] In an embodiment of the composition according to the present invention, as described above, the compound represented by formula (1), (2), (3), Compound (4), or preferred compounds, such as (M-1) to (M-63), or In addition to 1 molar equivalent of the total of all compounds of the type, As mentioned above, it is preferable if 0.05 to 0.3 molar equivalents of the crosslinker are provided.
[0083] In an embodiment of the composition according to the present invention, as described above, the compound represented by formula (1), (2), (3), Compound (4), or preferred compounds, such as (M-1) to (M-63), or In addition to 1 molar equivalent of the total of all compounds of the type, As described above, it is preferred that the composition contains 0.007 to 0.02 molar equivalents of UV absorber. stomach.
[0084] In an embodiment of the composition according to the present invention, as described above, the compound represented by formula (1), (2), (3), Compound (4), or preferred compounds, such as (M-1) to (M-63), or One mole equivalent of the sum of all compounds of the type, and hydrophilic, non-hydrophilic monomers, crosslinking In addition to the above molar equivalents of the total of the agent and the ultraviolet absorbing agent, As described, 0 to 0.004 molar equivalents of blue absorbing agent, or preferably as described or preferably, as described, from 1 micromolar equivalent to 0.004 moles of the total blue absorbing agent. of blue absorbing agent in an equivalent amount or particularly preferably as described or preferably as described It is preferred if a total of 8 micromolar equivalents to 0.002 molar equivalents is provided.
[0085] The preferred choice of the amount of blue absorber depends on the position of the band and the corresponding extinction coefficient. As a result, the skilled artisan can adapt the above-mentioned equivalent amounts of molar blue absorbing agent accordingly. This is in accordance with the invention with respect to the UV / The amount of blue absorber must be selected to affect the VIS spectrum. stomach. In the composition according to the invention, as described above or preferably as described above, The radical initiator, as described above, is also capable of causing polymerization of the monomer composition according to the present invention. It is added so that it can be used. The terms initiator, free radical starter, or free radical initiator are used interchangeably. It is used.
[0086] The polarization is preferably initiated by free radicals, both thermal initiators, e.g. Acetyl peroxide, stearoyl peroxide, 2,2'-azo-bis-(isobutyric acid nitrile), tert-butyl peroxypivalate, 2,2'-azobis-(2-cyanobenyl) Tanninnitrile), Benzoyl Peroxide, Lupero® TBEC, 2,2 '-(Diazene-1,2-diyl)bis(2,4-dimethyl-pentanenitrile), deca Noyl peroxide, di(tert-butylcyclohexyl) peroxydicarbonate, uryl peroxide, tert-butyl peroxydiethyl acetate, tert-butyl peroxy cis-2-ethylhexanoate, tert-amylperoxy-2-ethylhexanoate, VA-086, 1,1'-azo-di(hexahydrobenzonitrile), 1,1-bis(3 (butylperoxy)-3,3,5-trimethylcyclohexane, peroxydicarbonyl nates, and also photochemical initiators, such as Darocur 2273, Da rocur3331, Darocur1164, Irgacur1850, Darocu r1700, Darocur1173, Irgacur 184, Darocur111 6, Darocur 2959, Benzoin methyl ether, Benzoin ethyl ether, Irgacur 651, 2,4,6-(trimethylbenzoyl)diphenylphosphine oxide oxide, bis(2,4,6-trimethylbenzoyl)phenylphosphine oxide, bis (2,6-Dichlorobenzoyl)-4-propylphenylphosphine oxide is It is suitable for the purpose.
[0087] A thermal initiator is preferably used. A thermal initiator as described above is preferably used. 1,1-bis(tert-butylperoxy)-3,3,5-trimethylcyclohexane , tertiary butyl peroxy-2-ethylhexanoate, and tertiary amyl peroxy- 2-Ethylhexanoate is present in the composition as described above or preferably as described below. Based on the total amount of all compounds of formula (1) present, preferably 0.0025 to 0.05 Molar equivalents are particularly preferably used as free radical initiators. As mentioned above, the present invention therefore further relates to a composition, wherein the composition comprises: A free radical initiator is provided. The present invention relates to a composition as described above or preferably as described above, characterized in that it comprises Pertaining to and about something: 1 molar equivalent of a compound of formula (1) as described above, or a preferred compound of formula (1), or 1 mole of the sum of all compounds of formula (1) as described above or preferably as described above. equivalent; 0.51 to 1.24 molar equivalents of a hydrophilic monomer as described above or preferably as described; 0 to 0 of a non-hydrophilic monomer not conforming to formula (1) as described above or preferably as described above. .2 molar equivalents; 0.05 to 0.5 molar equivalents of a crosslinker as described above or preferably as described; 0.005 to 0.05 molar equivalents of an ultraviolet absorber as described above or preferably as described; 0 to 0.004 molar equivalents of a blue absorbing agent as described above or preferably as described; 0.025 to 0.05 molar equivalents of a free radical initiator as described above or preferably as described above. The present invention relates to a composition as described above or preferably as described above, characterized in that it comprises Pertaining to and about something: 1 molar equivalent of a compound of formula (1) as described above, or a preferred compound of formula (1), or 1 mole of the sum of all compounds of formula (1) as described above or preferably as described above. equivalent; 0.51 to 1.24 molar equivalents of a hydrophilic monomer as described above or preferably as described; 0 to 1 of a non-hydrophilic monomer not conforming to formula (1) as described above or preferably as described above. .0 molar equivalents; 0.04 to 0.5 molar equivalents of crosslinker as described above or preferably as described; 0.005 to 0.05 molar equivalents of an ultraviolet absorber as described above or preferably as described; 0 to 0.004 molar equivalents of a blue absorbing agent as described above or preferably as described; 0.025 to 0.05 molar equivalents of a free radical initiator as described above or preferably as described above. The present invention relates to a composition as described above or preferably as described above, characterized in that it comprises Pertaining to and about something: 1 molar equivalent of a compound of formula (1) as described above, or a preferred compound of formula (1), or 1 mole of the sum of all compounds of formula (1) as described above or preferably as described above. equivalent; 0.51 to 1.24 molar equivalents of a hydrophilic monomer as described above or preferably as described; 0 to 0 of a non-hydrophilic monomer not conforming to formula (1) as described above or preferably as described above. .2 molar equivalents; 0.05 to 0.5 molar equivalents of a crosslinker as described above or preferably as described; 0.005 to 0.05 molar equivalents of an ultraviolet absorber as described above or preferably as described; 0 to 0.004 molar equivalents of a blue absorbing agent as described above or preferably as described; 0.025 to 0.05 molar equivalents of a free radical initiator as described above or preferably as described above. In this embodiment, as described above, the molar equivalents of the indicated constituents are preferably the corresponding This rule applies. The present invention relates to a composition as described above or preferably as described above, characterized in that it comprises Pertaining to and about something: 1 molar equivalent of a compound of formula (1) as described above, or a preferred compound of formula (1), or 1 mole of the sum of all compounds of formula (1) as described above or preferably as described above. equivalent; 0.51 to 1.24 molar equivalents of a hydrophilic monomer as described above or preferably as described; As described above or preferably as described above, 0 to 1.0 molar equivalents of non-hydrophilic monomers, preferably or 0 to 0.2 molar equivalents of a non-hydrophilic monomer not conforming to formula (1); 0.04 to 0.5 molar equivalents of crosslinker as described above or preferably as described; 0.005 to 0.05 molar equivalents of an ultraviolet absorber as described above or preferably as described; 0 to 0.004 molar equivalents of a blue absorbing agent as described above or preferably as described; 0.025 to 0.05 molar equivalents of a free radical initiator as described above or preferably as described above.
[0088] For the composition, the form and preferred form of the composition may be combined as desired. In each case, the preferences of the respective components and their amounts are When desirable aspects are combined, it is preferred.
[0089] When the composition according to the invention is polymerized as described above or preferably as described above, As mentioned above, it has all the advantages of being soft from ambient temperatures between 16°C and 20°C. Crosslinked copolymers are formed. They are particularly suitable for use in coatings that exhibit a shimmer or substantially shimmering effect. The term "sparkle-free or substantially sparkle-free" shall have the meaning set forth above. The copolymer has a glass transition temperature (Tg) of 15° C. or less and a viscosity of at least 1.5, Preferably, the refractive index is at least 1.52, where the inducible change in refractive power is However, it is preferably at least 0.005 (ΔnD=0.005). The present invention therefore comprises a composition for polymerization as described above or preferably as described. The present invention further relates to crosslinked copolymers which can be used in the present invention. The present invention therefore relates to a process for the preparation of a polymerizable composition as described above or preferably as described herein. The present invention further relates to a crosslinked copolymer comprising:
[0090] The reaction conditions for free radical polymerization are well known to those skilled in the art of polymer chemistry. As described above, the compounds of formula (1) or preferred embodiments thereof are generally Due to the special aqueous character, in the compositions according to the invention, in particular the use of hydrophilic monomers Due to the presence of fluorine, the miscibility of the components may be limited. However, those skilled in the art will appreciate that a homogeneous Carefully select the initiator and the temperature of the thermal process to ensure that the copolymer is formed. In the case of a confirmed miscibility gap, the process can be selected if The polymerization temperature must be chosen so that it is not within the miscibility gap.
[0091] Those skilled in the art can identify material incompatibilities that can lead to miscibility gaps. He can, for example, as described above, apply a composition according to the invention with a suitable light source. The object can be irradiated and the UV / VIS spectrum recorded at various temperatures. The length is between 450 nm and 750 nm. For example, the transmission is When the temperature is plotted against the temperature, if the increase in transmission increases dramatically, the miscibility gap is confirmed. The increase in transmission can be explained by a sudden decrease in the density of the mixture where separation occurs. With the aid of this type of test, a person skilled in the art can determine whether thermally induced free radiation A suitable temperature for the polymerization can be selected.
[0092] As stated above, the present invention relates to a method for producing a composition comprising the above-mentioned or preferably the above-mentioned components. A composition according to the invention is provided which comprises or consists of The reaction mixture is subjected to a thermal polymerization, where in the case of the use of a thermal free radical initiator, the polymerization temperature to be selected is Crosslinked copolymers characterized in that they are not within the miscibility gap of the materials of the provided composition. The present invention therefore further relates to a process for the preparation thereof. The polymerization is preferably carried out without a solvent, as described above.
[0093] The properties of the copolymers according to the invention as raw materials for the production of ophthalmic products are It can be determined using methods such as refractometry with and without irradiation. Sparkle and water absorption can be measured by incubating the sample at a certain temperature and for a certain time. This was determined by scanning the cells, generating a multi-focus image, and counting the number of vacuoles on the image. can be.
[0094] Vacuole numbers are reported and normalized to volume. Water uptake was measured by incubation in water, e.g. The mass difference before and after the reaction can be used to determine the material properties of the polymer. These techniques are well known in the prior art and are not limiting in any way. The methods used for characterization of the crosslinked copolymers are described in the experimental section. Further details are provided in the following sections, which should not be construed as limiting.
[0095] The present invention relates to a method for producing an ophthalmic product, preferably an ophthalmic lens or an ophthalmic implant, in particular As described above or preferably for the production of blanks for intraocular lenses As described, the composition, as described above or preferably as described, is prepared from a polymerized composition. The present invention further relates to the use of the resulting crosslinked copolymers as well.
[0096] The term blank can also be used synonymously with the term semi-finished product, their base forms To the extent that the required work steps for the production of the final product are significantly reduced It also describes products made from one raw material or from a group of raw materials. A blank is a solid body, prefabricated to certain dimensions and geometrically specified; Corresponds to certain standards and certification criteria. Known from the metal industry, resulting from "semi-finished product manufacturing". The term semi-finished products covers products made not only from metals or metal alloys but also from plastics It also applies correspondingly to the manufacture of pharmaceutical products, including ophthalmic products.
[0097] The present invention therefore relates to a method for producing a composition according to the invention as described above or preferably as described herein. Further related to the article comprising the polymer or polymerized composition according to the present invention. Thus, the product has the same advantages as described for the copolymer according to the present invention. The statements apply correspondingly. The product is not limited to any particular shape, and is preferably a blank or finished ophthalmic product, preferably Preferably, it is an ophthalmic lens or an ophthalmic implant, particularly preferably an intraocular lens or a phakic ophthalmic lens. It is an inner lens.
[0098] The present invention therefore relates to an ophthalmic lens or ophthalmic implant, an ophthalmic implant, or a method for the preparation of an ophthalmic lens. The present invention further relates to a product as described above selected from the blanks. As mentioned above, for both the haptics and also the central optical lens, The copolymer or polymerized composition according to the present invention can be used in any type of ophthalmic lens. Lenses, preferably without limitation intraocular lenses or phakic lenses, may be used. The materials of the present invention can be further combined with known materials for the production of ophthalmic lenses. This can be achieved, for example, by adjusting the haptics relative to the central optical lens. This would be true if the intraocular lens were intended to be made of various plastics. Those skilled in the art in the field of production will appreciate that the processing steps required for the production of blanks and finished products are is knowledgeable in.
[0099] Free radical polymerization of the composition according to the invention, as described above or preferably as described For example, it can be carried out in a polymeric form as described above. Methods and techniques are known in this respect. Corresponding examples are given in the experimental section.
[0100] As mentioned above or preferably as described above, the present invention therefore provides a method for producing a method for the production of a medicament for use in a pharmaceutical composition comprising the steps of: A composition according to the invention is provided, polymerization is carried out, and the product is produced simultaneously or sequentially. The present invention relates to a process for the production of a product, characterized in that the product is formed by For example, it can be produced by molding as a blank, which is The resulting product is then converted into a finished product, e.g. an ophthalmic lens, as shown in Fig. 1. Further manufacturing steps by cutting Such techniques are well known to those skilled in the art.
[0101] Even without further comment, those skilled in the art can utilize the above description in its broadest form. It is envisaged that this would be possible. A preferred embodiment would therefore be It should merely be regarded as a non-limiting descriptive disclosure. All temperatures, above and below, are presented in °C. The invention is explained in more detail by the following examples, without however being limited thereto. example Example 1 - Preparation of Compounds A, B, C, and D: Compound A, corresponding to (M-23), 12-((2-oxo-3-(4-pentyl-2- (Trifluoromethyl)phenyl)-2H-chromen-7-yl)oxy)dodecylac Relate:
[0102] [ka] Compound B, corresponding to (M-20), 12-((2-oxo-3-(4-pentyl-2- (Trifluoro-methoxy)phenyl)-2H-chromen-7-yl)oxy)dodecyl Acrylates:
[0103] [ka] Compound C, corresponding to (M-42), 12-((2-oxo-3-(4-pentyl-2- (Trifluoro-methoxy)phenyl)-2H-chromen-7-yl)oxy)dodecyl Methacrylate:
[0104] [ka] Compound D, corresponding to (M-33), 11-(2-oxo-3-(4-pentyl-2-( Trifluoro-methoxy)phenyl)-2H-chroman-7-yl)undecyl acryl Thread:
[0105] [ka] The preparation of the above compound A is shown in Scheme 1, the preparation of compounds B and C is shown in Scheme 2, and The preparation of compound D is depicted in Scheme 3:
[0106] [ka]
[0107] [ka]
[0108] [ka] Example 2: Polymerization As can be seen in Table 1 below, the monomers used were purchased commercially and without further purification. Used for. General steps: The corresponding compositions according to the invention may be prepared by mixing the individual components as set forth in Table 1. Prepare in a flask by mixing and degassing.
[0109] The polymerization is carried out without solvent. The polymerization mold is formed into a sheet of suitable thickness, for example between 1 and 3 mm. It is located inside the recon mat, and from there, a sample, for example 1mm x 25mm x 30-70m 1. Cut out a bar of 1.m or the corresponding desired blank and fill channel shape, and Then, lay a silicone mat between the two glass plates. A separating layer, e.g. a PET film, The polymerisation conditions are in each case laid between a glass plate and a silicone mat. The selection depends on the initiator, which is obvious to one skilled in the art from the respective mixture composition. The amount of initiator is also indicated in Table 1. The polymerization temperature was 70°C and 180°C. It is between °C. C18MA = Octadecyl methacrylate HEMA = 2-hydroxyethyl methacrylate EGDMA = ethylene glycol dimethacrylate UVabs = 2-[3-(2H-benzotriazol-2-yl)-4-hydroxyphenyl Nyl]ethyl methacrylate DtCyP = 1,1-bis(tert-butylperoxy)-3,3,5-trimethyl Cyclohexane
[0110] [Table 1] Compositions according to the invention are indicated by *. Materials from the polymerization of compositions 1 to 10 in Table 1 are characterized using the following method: : Refractometer method The refractive index nD is calculated using the Schmidt-Haensch model ATR-Lambda multiwave Determined by refractometer. Measurements are carried out at 20°C. Illumination and refractive index fluctuations
[0111] The sample is covered with borosilicate glass and illuminated with a 125 W mercury high pressure lamp. The refractive index is determined during the measurement. Irradiation is continued until no refractive index fluctuations are observed. The difference between the index of refraction and the index of refraction after irradiation is referred to as ΔnD. Sparkle (GT) Water Absorbency (WA)
[0112] A sample having a thickness of 1 mm, for example a disk having a diameter of 9.5 mm and a thickness of 1 mm The samples are then incubated in water at 45°C for 24 hours. The samples are then incubated at 37°C for an additional 2. Incubate in warm water for 5 hours. Samples treated in this manner are examined under a microscope. do.
[0113] A series of images with different focal planes were taken using a microscope (M The images were recorded in dark field using a 205FA (Leica). To do this, connect them together and count the vacuoles on this image. The number of vacuoles is presented. and normalized to volume. Water absorption was measured by mass spectrometry before and after incubation in water at 45°C or 30°C for 72 hours. It is determined by the difference between
[0114] [Table 2]
[0115] The results for the polymerized compositions 1-10 (corresponding to copolymers 1-10) show that the hydrophilic components With the addition of HEMA, good refractive index variation is still achieved, but the HE When the amount of MA is selected according to the invention, opacification occurs in the sparkle test. It is clearly shown that the copolymers of the polymerized compositions 4, 5, 6, and 7 are not It is still transparent, and moreover, it does not exhibit opacification after the sparkle, i.e. That is, virtually no sparkle is evident, and the number of vacuoles is This corresponds to the 0th level on the scale introduced. Polymerized compositions 4-7 according to the invention are ideal. All material properties taken together are Where considered, the polymerized composition 5 is particularly preferred. Example 3: The following compositions are polymerized analogously to Example 2 and measured according to Example 2:
[0116] [Table 3]
[0117] The results are shown in Table 4. [Table 4]
[0118] The results of the polymerized compositions 11 to 17 show that the addition of hydrophilic components results in favorable refractive index changes. is still achieved, however, when the amount of hydrophilic component is selected in accordance with the present invention. If so, it clearly indicates that no opacification occurs in the sparkle test.
[0119] [Embodiment] (1) A composition comprising: At least one compound of formula (1), the following applies to the symbols and indices used: [ka] X, in each occurrence, is the same or different and is O, S or NR 0 and; Y, in each occurrence, is the same or different, O or S; X 1 is O or S; a is 0 or 1; Sp is alkanediyl, alkenediyl, or alkynediyl, which is optionally substituted by one or more groups R; R 0 is a linear or branched alkyl group having 1 to 10 carbon atoms; R 1 , R 2 , R 3 and R 4 are, in each case, independently of each other at each occurrence, H, F, Cl, Br, I, a linear or branched alkyl group having 1 to 20 carbon atoms, a partially or fully halogenated linear or branched alkyl group having 1 to 20 carbon atoms, an aryl or heteroaryl group having 5 to 40 ring atoms; R 5 , R 6 , R 7 , R 8 , and R 9 are, in each case and in each occurrence, independently of one another, H, F, Cl, Br, I, a linear or branched alkyl group having 1 to 20 carbon atoms, a linear or branched alkoxy group having 1 to 20 carbon atoms, a partially or fully halogenated linear or branched alkyl group having 1 to 20 carbon atoms, a partially or fully halogenated linear or branched alkoxy group having 1 to 20 carbon atoms, or an aryl or heteroaryl group having 5 to 40 ring atoms, in which the substituent R 5 ~R 9 at least one radical from the group consisting of represents a linear or branched alkyl radical having 1 to 20 carbon atoms, which may be partially or fully halogenated; R 10 , R 11 , R 12 are, in each case and in each occurrence, independently of one another, H, F, a linear or branched alkyl group having 1 to 20 carbon atoms, which may be partially or fully halogenated, or an aryl group having 6 to 14 carbon atoms; R, in each occurrence, is the same or different and is selected from the group consisting of linear or branched alkyl groups having 1 to 10 carbon atoms, partially or fully halogenated linear or branched alkyl groups having 1 to 10 carbon atoms, linear or branched alkoxy groups having 1 to 10 carbon atoms, or partially or fully halogenated linear or branched alkoxy groups having 1 to 10 carbon atoms; at least one hydrophilic monomer, such that the non-crosslinked homopolymer is water soluble or swellable in water; at least one UV absorber and at least one crosslinker, of all compounds of formula (1) in total, relative to the sum of all hydrophilic monomers Rumo The ratio of the fluorine-containing gas to the fluorine-containing gas is 1:0.51 to 1:1.24. (2) at least one additional non-hydrophilic monomer not conforming to formula (1) and / or blue absorbing 2. The composition of embodiment 1, further comprising a collector. (3) 1 molar equivalent of a compound of formula (1) or 1 molar equivalent of all compounds of formula (1) combined; 0.51 to 1.24 molar equivalents of hydrophilic monomer; 0 to 1.0 molar equivalents of a non-hydrophilic monomer not conforming to formula (1); 0.04 to 0.5 molar equivalents of a crosslinker; and 3. The composition according to embodiment 1 or 2, comprising 0.005 to 0.05 molar equivalents of UV absorber. (4) The composition according to any one of the preceding claims, characterized in that the composition comprises a free radical initiator. (5) 1 molar equivalent of a compound of formula (1) or 1 molar equivalent of all compounds of formula (1) in total; 0.51 to 1.24 molar equivalents of hydrophilic monomer; 0 to 1.0 molar equivalents of a non-hydrophilic monomer not conforming to formula (1); 0.04-0.5 molar equivalents of crosslinker; 0.005 to 0.05 molar equivalents of UV absorber; 0 to 0.004 molar equivalents of a blue absorbing agent; and 5. The composition according to any one of the preceding embodiments, characterized in that it comprises 0.0025 to 0.05 molar equivalents of a free radical initiator.
[0120] (6) At least one hydrophilic monomer is 3-hydroxypropyl methacrylate, 3-hydroxypropyl methacrylate, 6. The composition according to any one of the preceding claims, characterized in that the alkyl group is selected from the group consisting of hydroxypropyl acrylate, 2-hydroxyethyl methacrylate, 2-hydroxyethyl acrylate, 4-hydroxybutyl methacrylate, 4-hydroxybutyl acrylate, glyceryl methacrylate, glyceryl acrylate, acrylamide, N-vinylpyrrolidone, 6-hydroxyhexyl methacrylate, 6-hydroxyhexyl acrylate, 18-hydroxyoctadecyl methacrylate, 18-hydroxyoctadecyl acrylate, 11-hydroxyundecyl methacrylate, 11-hydroxyundecyl acrylate, 12-hydroxydodecyl methacrylate, 12-hydroxydodecyl acrylate, ethylene glycol phenyl ether acrylate, ethylene glycol phenyl ether methacrylate, or a combination of these compounds. (7) The crosslinking agent is paradivinylbenzene, allyl acrylate, ethylene glycol divinyl ether, divinyl sulfone, allyl methacrylate, N,N'-methylenebisacrylamide, ethylene glycol diacrylate, N,N'-methylene-bis-methacrylamide, 1,3-propanediol diacrylate, 2,3-propanediol diacrylate, 1,4-butanediol diacrylate, 1,3-butanediol diacrylate, 1,5-pentanediol diacrylate, 1,6-hexanediol diacrylate, 1,7-heptanediol diacrylate Acrylate, 1,8-octanediol diacrylate, 1,9-nonanediol diacrylate, 1,10-decanediol diacrylate, 1,11-undecanediol diacrylate, 1,12-dodecanediol diacrylate, 1,13-tridecanediol diacrylate, 1,14-tetradecanediol diacrylate, 1,15-pentadecanediol diacrylate, 1,16-hexadecanediol diacrylate, 1,17-heptadecanediol diacrylate, 1,18-octadecanediol diacrylate, 1, 19-Nona-decanediol diacrylate, 1,20-Eicosanediol diacrylate, 1,21-Heneicosanediol diacrylate, 1,22-Docosanediol diacrylate, 1,23-Tricosanediol diacrylate, 1,24-Tetracosanediol diacrylate, Ethylene glycol dimethacrylate, N,N'-Dihydroxyethylenebisacrylamide, Thiodiethylene glycol diacrylate, 1,3-Propanediol dimethacrylate, 2,3-Propanediol dimethacrylate, 1,3-Butanediol dimethacrylate, 1,4-butanediol dimethacrylate, 1,5-pentanediol dimethacrylate, 1,6-hexanediol dimethacrylate, 1,7-heptanediol dimethacrylate, 1,8-octanediol dimethacrylate, 1,9-nonanediol dimethacrylate, 1,10-decanediol dimethacrylate, 1,11-undecanediol dimethacrylate, 1,12-dodecanediol dimethacrylate, 1,13-tridecanediol dimethacrylate, 1,14-tetradecanediol dimethacrylate, 1,15-Pentadecanediol dimethacrylate, 1,16-Hexadecanediol dimethacrylate, 1,17-Heptadecanediol dimethacrylate, 1,18-Octadecanediol dimethacrylate, 1,19-Nonadecanediol dimethacrylate, 1,20-Eicosanediol dimethacrylate, 1,21-Heneicosanediol dimethacrylate, 1,22-Docosanediol dimethacrylate, 1,23-Tricosanediol dimethacrylate, 1,24-Tetradecanediol dimethacrylate acrylate, 2-(acryloyloxy)ethyl methacrylate, 2-(acryloyloxy)propyl methacrylate, 3-(acryloyloxy)propyl methacrylate, 4-(acryloyloxy)butyl methacrylate, 5-(acryloyloxy)pentyl methacrylate, 6-(acryloyloxy)hexyl methacrylate, 7-(acryloyloxy)heptyl methacrylate, 8-(acryloyloxy)octyl methacrylate, 9-(acryloyloxy)nonyl methacrylate, 10 -(Acryloyloxy)decyl methacrylate, 11-(acryloyloxy)undecyl methacrylate, 12-(acryloyloxy)dodecyl methacrylate, 13-(acryloyloxy)tridecyl methacrylate, 14-(acryloyloxy)tetradecyl methacrylate, 15-(acryloyloxy)pentadecyl methacrylate, 16-(acryloyloxy)hexadecyl methacrylate, 17-(acryloyloxy)heptadecyl methacrylate, 18-(acryloyloxy) Oxy)octadecyl methacrylate, 19-(acryloyloxy)nonadecyl methacrylate, 20-(acryloyloxy)eicosanyl methacrylate, 21-(acryloyloxy)heneicosanyl methacrylate, 22-(acryloyloxy)-docosanyl methacrylate, 23-(acryloyloxy)tricosanyi methacrylate, 24-(acryloyloxy)tetracosanyl methacrylate, neopentyl glycol diacrylate, di(ethylene glycol) diacrylate, N,Composition according to any one of the preceding claims, characterized in that the aryl group is selected from N'-hexamethylenebisacrylamide, thiodiethylene glycol diacrylate, thiodiethylene glycol dimethacrylate, neopentyl glycol dimethacrylate, diethylene glycol dimethacrylate, diallyl phthalate, triallyl cyanurate, glyceryl 1,3-dimethacrylate, N,N'-hexamethylenebismethacrylamide, tri(ethylene glycol) diacrylate, tri(ethylene glycol) dimethacrylate, tetra(ethylene glycol) diacrylate, tetra(ethylene glycol) dimethacrylate, penta(ethylene glycol) diacrylate, penta(ethylene glycol) dimethacrylate, hexa(ethylene glycol) diacrylate, hexa(ethylene glycol) dimethacrylate, poly(ethylene glycol) dimethacrylate, poly(ethylene glycol) diacrylate. (8) The ultraviolet absorber is 3-(3-(tertiary butyl)-4-hydroxy-5-(5-methoxy-2H-benzo[d]-1,2,3-triazol-2-yl)-phenoxy)propyl methacrylate, 2-(2-hydroxy-5-vinylphenyl)-2H-benzo-triazole, allyl-2-hydroxybenzophenone, 2-allyl-6-(2H-benzotriazol-2-yl)-p-cresol, 4-methacryloxy-2-hydroxybenzophenone, 2-(2'-hydroxy-3'-methallyl-5'-methy 2-(2'-hydroxy-5'-methacrylamidophenyl)benzotriazole, 2-hydroxy-4-methacryloxyloxybenzophenone, 4-acryloylethoxy-2-hydroxybenzophenone, 2-[3-(2H-benzotriazol-2-yl)-4-hydroxyphenyl]ethyl methacrylate, 2-(2'-hydroxy-5'-methacrylamidophenyl)-5-methoxybenzotriazole, 2-(2'-hydroxy-5'-methacrylamidophenyl)-5-chlorobenzotriazole, 2-(2'-hydroxy- 5'-Methacryloxypropylphenyl)benzotriazole, 2-(2'-hydroxy-5'-methacryloxypropyl-3'-tertiary-butyl-phenyl)-5-methoxy-2H-benzotriazole, 2-(3-(tertiary butyl)-4-hydroxy-5-(5-methoxy-2H-benzo[d]-1,2,3-triazol-2-yl)phenoxy)ethyl methacrylate, 2-[3'-tertiary-butyl-2'-hydroxy-5'-(3''-methacryloxypropyl)phenyl]-5 -Chlorobenzotriazole, 2-{2'-hydroxy-3'-tertiary-butyl-5'-[3'-methacryloxypropoxy]phenyl}-5-methoxy-2H-benzotriazole, 2-[3'-tertiary-butyl-5'-(3''-dimethylvinylsilylpropoxy)-2'-hydroxyphenyl]-5-methoxybenzotriazole, 2-(tertiary-butyl)-6-(5-chloro-2H-benzo[d]-1,2,3-triazol-2-yl)-4-vinylphenol, 2-(2H-1,2,The composition according to any one of the preceding embodiments, characterized in that the ester is selected from the group consisting of 3-benzotriazol-2-yl)-4-methyl-6-(2-methylprop-2-enyl)phenol, 2-(3-acetyl-2-aminophenoxy)ethyl methacrylate, 2-(4-benzoyl-3-hydroxyphenoxy)ethyl acrylate, or a combination of these compounds. (9) A crosslinked copolymer comprising the polymerized composition according to any one of the first to eighth embodiments. (10) A process for the preparation of a copolymer according to embodiment 9, characterized in that a composition according to any of embodiments 1 to 8 is provided and subsequently subjected to free radical polymerization, wherein the polymerization temperature to be selected for the use of a thermal free radical initiator is not within the miscibility gap of the materials.
[0121] (11) Use of a composition according to any of embodiments 1 to 8 or a copolymer according to embodiment 9 for the production of ophthalmic lenses or blanks for ophthalmic implants. (12) The use according to embodiment 11 for producing an intraocular lens. (13) An article of manufacture comprising the copolymer of embodiment 9. (14) Blanks for ophthalmic lenses or ophthalmic implants, and ophthalmic implants or ophthalmic lenses; The product of embodiment 13, preferably selected from an intraocular lens or a phakic lens. (15) A process for producing the product according to embodiment 13, characterized in that a composition according to any of embodiments 1 to 8 is provided, polymerization is carried out, and the product is shaped simultaneously or subsequently, preferably by molding.
Claims
1. A composition comprising: At least one compound of formula (1), the following applies to the symbols and indices used: 【Chemistry 1】 X, in each occurrence, is the same or different and is O, S or NR 0 and Y, in each occurrence, is the same or different, and is O or S; X 1 is O or S; a is 0 or 1; Sp is alkanediyl, alkenediyl, or alkynediyl, which may be substituted by one or more groups R; R 0 is a linear or branched alkyl group having 1 to 10 carbon atoms; R 1 , R 2 , R 3 and R 4 are, in each case, independently of each other at each occurrence, H, F, Cl, Br, I, a linear or branched alkyl group having 1 to 20 carbon atoms, a partially or fully halogenated linear or branched alkyl group having 1 to 20 carbon atoms, or an aryl or heteroaryl group having 5 to 40 ring atoms; R 5 , R 6 , R 7 , R 8 , and R 9 are, in each case and in each occurrence, independently of one another, H, F, Cl, Br, I, a linear or branched alkyl group having 1 to 20 carbon atoms, a linear or branched alkoxy group having 1 to 20 carbon atoms, a partially or fully halogenated linear or branched alkyl group having 1 to 20 carbon atoms, a partially or fully halogenated linear or branched alkoxy group having 1 to 20 carbon atoms, or an aryl or heteroaryl group having 5 to 40 ring atoms, in which the substituent R 5 ~R 9 at least one radical from the group: represents a linear or branched alkyl radical having 1 to 20 carbon atoms, which may be partially or fully halogenated; R 10 , R 11 , R 12 are, in each case and at each occurrence, independently of one another, H, F, a linear or branched alkyl group having 1 to 20 carbon atoms, which may be partially or fully halogenated, or an aryl group having 6 to 14 carbon atoms; R, in each occurrence, is the same or different and is selected from the group consisting of linear or branched alkyl groups having 1 to 10 carbon atoms, partially or fully halogenated linear or branched alkyl groups having 1 to 10 carbon atoms, linear or branched alkoxy groups having 1 to 10 carbon atoms, or partially or fully halogenated linear or branched alkoxy groups having 1 to 10 carbon atoms; at least one hydrophilic monomer; at least one ultraviolet absorber and at least one crosslinker, wherein the molar ratio of the sum of all said at least one compound of formula (1) to the sum of all said at least one hydrophilic monomer is from 1:0.51 to 1:1.24; A composition, wherein the at least one hydrophilic monomer comprises an n-hydroxyalkyl acrylate, an n-hydroxyalkyl methacrylate, or a combination of these compounds having 1 to 18 carbon atoms in the alkyl chain.
2. 2. The composition of claim 1, wherein the at least one hydrophilic monomer further comprises an n-hydroxyalkyl acrylamide, an n-hydroxyalkyl methacrylamide, or a combination of these compounds having 1 to 18 carbon atoms in the alkyl chain.
3. 3. The composition according to claim 1 or 2, characterized in that it comprises at least one further non-hydrophilic monomer not conforming to formula (1) and / or blue absorbing agent.
4. 1 molar equivalent of the sum of all of said at least one compound of formula (1); 0.51 to 1.24 molar equivalents of the total amount of all said at least one hydrophilic monomer; 0 to 1.0 molar equivalents of a non-hydrophilic monomer not conforming to formula (1); 0.04 to 0.5 molar equivalents of said at least one crosslinker; and The composition according to any one of claims 1 to 3, characterized in that it comprises 0.005 to 0.05 molar equivalents of said at least one UV absorber.
5. A composition according to any one of claims 1 to 4, characterized in that it comprises a free radical initiator.
6. 1 molar equivalent of the sum of all of said at least one compound of formula (1); 0.51 to 1.24 molar equivalents of the total amount of all said at least one hydrophilic monomer; 0 to 1.0 molar equivalents of a non-hydrophilic monomer not conforming to formula (1); 0.04 to 0.5 molar equivalents of said at least one crosslinker; 0.005 to 0.05 molar equivalents of said at least one ultraviolet light absorber; 0 to 0.004 molar equivalents of a blue absorbing agent; and A composition according to any one of claims 1 to 5, characterized in that it comprises from 0.0025 to 0.05 molar equivalents of a free radical initiator.
7. The at least one crosslinking agent is paradivinylbenzene, allyl acrylate, ethylene glycol divinyl ether, divinyl sulfone, allyl methacrylate, N,N'-methylenebisacrylamide, ethylene glycol diacrylate, N,N'-methylene-bis-methacrylamide, 1,3-propanediol diacrylate, 2,3-propanediol diacrylate, 1,4-butanediol diacrylate, 1,3-butanediol diacrylate, 1,5-pentanediol diacrylate, 1,6-hexanediol diacrylate, 1,7-heptanediol diacrylate acrylate, 1,8-octanediol diacrylate, 1,9-nonanediol diacrylate, 1,10-decanediol diacrylate, 1,11-undecanediol diacrylate, 1,12-dodecanediol diacrylate, 1,13-tridecanediol diacrylate, 1,14-tetradecanediol diacrylate, 1,15-pentadecanediol diacrylate, 1,16-hexadecanediol diacrylate, 1,17-heptadecanediol diacrylate, 1,18-octadecanediol diacrylate, 1, 19-nonadecanediol diacrylate, 1,20-eicosanediol diacrylate, 1,21-heneicosanediol diacrylate, 1,22-docosanediol diacrylate, 1,23-tricosanediol diacrylate, 1,24-tetracosanediol diacrylate, ethylene glycol dimethacrylate, N,N'-dihydroxyethylenebisacrylamide, thiodiethylene glycol diacrylate, 1,3-propanediol dimethacrylate, 2,3-propanediol dimethacrylate, 1,3-butanediol dimethacrylate, 1,4-butanediol dimethacrylate, 1,5-pentanediol dimethacrylate, 1,6-hexanediol dimethacrylate, 1,7-heptanediol dimethacrylate, 1,8-octanediol dimethacrylate, 1,9-nonanediol dimethacrylate, 1,10-decanediol dimethacrylate, 1,11-undecanediol dimethacrylate, 1,12-dodecanediol dimethacrylate, 1,13-tridecanediol dimethacrylate, 1,14-tetradecanediol dimethacrylate, 1,15-Pentadecanediol dimethacrylate, 1,16-Hexadecanediol dimethacrylate, 1,17-Heptadecanediol dimethacrylate, 1,18-Octadecanediol dimethacrylate, 1,19-Nonadecanediol dimethacrylate, 1,20-Eicosanediol dimethacrylate, 1,21-Heneicosanediol dimethacrylate, 1,22-Docosanediol dimethacrylate, 1,23-Tricosanediol dimethacrylate, 1,24-Tetradecanediol dimethacrylate acrylate, 2-(acryloyloxy)ethyl methacrylate, 2-(acryloyloxy)propyl methacrylate, 3-(acryloyloxy)propyl methacrylate, 4-(acryloyloxy)butyl methacrylate, 5-(acryloyloxy)pentyl methacrylate, 6-(acryloyloxy)hexyl methacrylate, 7-(acryloyloxy)heptyl methacrylate, 8-(acryloyloxy)octyl methacrylate, 9-(acryloyloxy)nonyl methacrylate, 10 -(acryloyloxy)decyl methacrylate, 11-(acryloyloxy)undecyl methacrylate, 12-(acryloyloxy)dodecyl methacrylate, 13-(acryloyloxy)tridecyl methacrylate, 14-(acryloyloxy)tetradecyl methacrylate, 15-(acryloxyloyloxy)pentadecyl methacrylate, 16-(acryloyloxy)hexadecyl methacrylate, 17-(acryloyloxy)heptadecyl methacrylate, 18-(acryloyloxy) 19-(acryloyloxy)octadecyl methacrylate, 19-(acryloyloxy)nonadecyl methacrylate, 20-(acryloyloxy)eicosanyl methacrylate, 21-(acryloyloxy)heneicosanyl methacrylate, 22-(acryloyloxy)-docosanyl methacrylate, 23-(acryloyloxy)tricosanyl methacrylate, 24-(acryloyloxy)tetracosanyl methacrylate, neopentyl glycol diacrylate, di(ethylene glycol) diacrylate, N,The composition according to any one of claims 1 to 6, characterized in that it is selected from N'-hexamethylenebisacrylamide, thiodiethylene glycol diacrylate, thiodiethylene glycol dimethacrylate, neopentyl glycol dimethacrylate, diethylene glycol dimethacrylate, diallyl phthalate, triallyl cyanurate, glyceryl 1,3-dimethacrylate, N,N'-hexamethylenebismethacrylamide, tri(ethylene glycol) diacrylate, tri(ethylene glycol) dimethacrylate, tetra(ethylene glycol) diacrylate, tetra(ethylene glycol) dimethacrylate, penta(ethylene glycol) diacrylate, penta(ethylene glycol) dimethacrylate, hexa(ethylene glycol) diacrylate, hexa(ethylene glycol) dimethacrylate, poly(ethylene glycol) dimethacrylate, poly(ethylene glycol) diacrylate.
8. The at least one ultraviolet absorber 3-(3-(tertiary butyl)-4-hydroxy-5-(5-methoxy-2H-benzo[d]-1,2,3-triazol-2-yl)-phenoxy)propyl methacrylate, 2-(2-hydroxy-5-vinylphenyl)-2H-benzo-triazole, allyl-2-hydroxybenzophenone, 2-allyl-6-(2H-benzotriazol-2-yl)-p-cresol, 4-methacryloxy-2-hydroxybenzophenone, 2-(2'-hydroxy-3'-methallyl-5'-methyl 2-(2'-hydroxy-5'-methacrylamidophenyl)benzotriazole, 2-hydroxy-4-methacryloxyloxybenzophenone, 4-acryloylethoxy-2-hydroxybenzophenone, 2-[3-(2H-benzotriazol-2-yl)-4-hydroxyphenyl]ethyl methacrylate, 2-(2'-hydroxy-5'-methacrylamidophenyl)-5-methoxybenzotriazole, 2-(2'-hydroxy-5'-methacrylamidophenyl)-5-chlorobenzotriazole, 2-(2'-hydroxy- 5'-Methacryloxypropylphenyl)benzotriazole, 2-(2'-hydroxy-5'-methacryloxypropyl-3'-tertiary-butyl-phenyl)-5-methoxy-2H-benzotriazole, 2-(3-(tertiary butyl)-4-hydroxy-5-(5-methoxy-2H-benzo[d]-1,2,3-triazol-2-yl)phenoxy)ethyl methacrylate, 2-[3'-tertiary-butyl-2'-hydroxy-5'-(3''-methacryloxypropyl)phenyl]-5 -chlorobenzotriazole, 2-{2'-hydroxy-3'-tertiary-butyl-5'-[3'-methacryloxyloxypropoxy]phenyl}-5-methoxy-2H-benzotriazole, 2-[3'tertiary-butyl-5'-(3''-dimethylvinylsilylpropoxy)-2'-hydroxyphenyl]-5-methoxybenzotriazole, 2-(tertiary butyl)-6-(5-chloro-2H-benzo[d]-1,2,3-triazol-2-yl)-4-vinylphenol, 2-(2H-1,2,The composition according to any one of claims 1 to 7, characterized in that the ester is selected from the group consisting of 3-benzotriazol-2-yl)-4-methyl-6-(2-methylprop-2-enyl)phenol, 2-(3-acetyl-2-aminophenoxy)ethyl methacrylate, 2-(4-benzoyl-3-hydroxyphenoxy)ethyl acrylate, or a combination of these compounds.
9. A crosslinked copolymer comprising the composition of any one of claims 1 to 8 polymerized therein.
10. A process for the preparation of crosslinked copolymers according to claim 9, characterized in that a composition according to any one of claims 1 to 8 is provided and subsequently subjected to free radical polymerization, in which the polymerization temperature to be selected for the use of a thermal free radical initiator is not within the miscibility gap of the materials.
11. Use of a composition according to any one of claims 1 to 8 or of a crosslinked copolymer according to claim 9 for the production of ophthalmic lenses or blanks for ophthalmic implants.
12. 12. Use according to claim 11 for the production of an intraocular lens.
13. An article of manufacture comprising the crosslinked copolymer of claim 9.
14. 14. The article of manufacture of claim 13 selected from blanks for ophthalmic lenses, blanks for ophthalmic implants, ophthalmic implants, and ophthalmic lenses.
15. The product described in claim 13, selected from an intraocular lens and a phakic lens.
16. A process for the production of a product according to claim 13, characterized in that a composition according to any one of claims 1 to 8 is provided, polymerization is carried out and said product is simultaneously or subsequently shaped.
17. A process for producing a product according to claim 13, characterized in that a composition according to any one of claims 1 to 8 is provided, polymerization is carried out and the product is shaped simultaneously or subsequently by a molding.
Citation Information
Patent Citations
Ophthalmic compositions and their use
JP2011505932A
Light-induced shape-changeable hydrogels and their use in optical devices
JP2017511169A
Compounds for optically active devices
WO2017032442A1
Compounds for optically active devices
WO2017032443A1
Hydrophilic compounds for optically active devices
WO2017032444A1
